Quarterlytics / Industrials / Hardware, Equipment & Parts / Ilika Plc

Ilika Plc

ika · LSE Industrials
Claim this profile
Ticker ika
Exchange LSE
Sector Industrials
Industry Hardware, Equipment & Parts
Employees 51-200
← All annual reports
FY2018 Annual Report · Ilika Plc
Sign in to download
Loading PDF…
PIONEERS IN 
SOLID-STATE

I

l

i

k

a

p

l

c

A

n

n

u

a

l

R

e

p

o

r

t

a

n

d

A

c

c

o

u

n

t

s

2

0

1

8

ANNUAL REPORT 
AND ACCOUNTS 2018

 
 
 
 
 
 
ILIKA IS A PIONEER IN  
SOLID-STATE BATTERY 
TECHNOLOGY AND  
MATERIALS INNOVATION

The past year has seen strong progress from Ilika 
both operationally and financially. The Stereax® 
pilot line has produced samples of Ilika’s batteries 
for evaluation by 12 partners around the world. 
Feedback from those evaluations has been positive 
and underpins our ongoing commercialisation 
efforts. Following market demand we have 
extended our roadmap to include large format 
Stereax® cells for automotive power and I was 
delighted to see that Innovate UK has offered 
to support Ilika in two of the Faraday Challenge 
automotive collaborations with £4.1 million of 
funding working with key industry players such 
as Honda, McLaren and Ricardo. Financially, 
revenue climbed over the £2 million mark, with 
expectations of further growth in the year to come.

Mike Inglis
Chairman, Ilika

01

STRATEGIC REPORT
01 
02 
06 
06 
12 
20 
21 

Highlights 2018
At a glance
Chief Executive’s review
Operating review
Business strategy
Financial review
Principal risks and uncertainties

CORPORATE GOVERNANCE
22 
24 
25 
28 
29 

Board of Directors
Directors’ report 
 Directors’ remuneration report
 Statement of Directors’ responsibilities
Corporate governance statement

FINANCIAL STATEMENTS
31 
34 
35 
36 
37 
38 
50 
51 
52 
53 
55 

Independent auditor’s report
 Consolidated statement of comprehensive income
 Consolidated balance sheet
 Consolidated cash flow statement
 Consolidated statement of changes in equity
 Notes to the consolidated financial statements
 Company balance sheet of Ilika plc
 Company cash flow statement
 Company statement of changes in equity
 Notes to the Company financial statements
 Corporate directory

OPERATIONAL HIGHLIGHTS

FINANCIAL HIGHLIGHTS

•  Implementation of Stereax® development programmes with 

three commercial partners:
–  Deployment in miniature medical implants with a leading 

bioelectronics company

–  Collaboration with Lightricity (ex-Sharp) to integrate 
Stereax® solid-state batteries with photovoltaic (‘PV’) 
technology 

–  Deployment of Stereax® M250 cells with Titan Wind 

Energy in condition monitoring devices for wind turbines

•  Collaboration with eight global OEMs to develop new 

functional materials:
–  Protected anodes for lithium sulphur batteries with 

Johnson Matthey 

–  Advanced battery materials and fuel cell catalysts that can 
power future zero-emissions and carbon-neutral vehicles 
with Toyota Research Institute 

–  Photonic materials for high capacity Hard Disk Drives 

with Seagate 

–  P-type semiconductors for flexible integrated circuits 

with PragmatIC and Arm
–  Superalloys with Rolls-Royce
–  Self-healing alloys with BAE Systems and GKN

•  Award of ISO 9001 certification to Ilika’s quality 

management system

•  Post year end: offer of £4.1 million grant funding from the 

Faraday Challenge to develop large format solid-state cells 
for automotive in collaboration with Honda, Ricardo, 
McLaren and A123 Batteries

REVENUES

£2.1M

(2017: £1.1m)

LOSS FOR THE YEAR

£2.9M

(2017: £3.5m)

LOSS PER  
SHARE

3.7P

(2017: 4.8p)

CASH, CASH EQUIVALENTS 
AND BANK DEPOSITS OF

£2.8M

(2017: £5.4m)

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201802

ILIKA AT A GLANCE

PRINCIPAL ACTIVITIES

Ilika plc is the holding company for Ilika Technologies Limited, a 
pioneer in solid-state battery technology and materials innovation. 
Ilika has developed ground-breaking solid-state battery technology 
(Stereax®). The Stereax® roadmap commences with miniature 
batteries designed to meet the demands of powering wireless devices, 
referred to as ‘the Internet of Things (‘IoT’)’. Stereax® technology was 
developed on Ilika’s unique, patent protected high throughput 
materials development platform, which accelerates the discovery 
of new and patentable materials for identified end uses in the 
automotive, aeronautical and electronics sectors. 

STEREAX® BATTERY 
TECHNOLOGY

MATERIALS  
INNOVATION

Miniaturised batteries are a critical 
enabler to current and emergent 
technologies, including wearables, 
medical devices and the IoT. Ilika has 
been working with solid-state battery 
technology since 2008 and offers 
its Stereax® battery technology to 
companies who need energy efficient 
batteries. These are energy dense 
batteries with the smallest possible 
footprint, with distinct benefits over 
lithium-ion batteries.

Ilika’s high throughput technology 
enables functional materials to be 
made, characterised and tested up  
to 100 times faster than traditional 
techniques. Its robust datasets fully 
define the performance of families  
of materials. This enhances 
intellectual property value, optimises 
product performance and reduces 
time to market, thereby minimising 
costs and maximising the return on 
your R&D investment.

The Stereax® P180 is a unique 
solid-state battery that can 
operate and be stored in the 
extended temperature range 
-40°C to +150°C.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201803

APPLICATIONS

INDUSTRIAL IOT 
•  Small unobtrusive  

beacons

•   High temperature 

environments

•  Retro-fitting existing 

equipment

AUTOMOTIVE 
•  Autonomous – increased 

range of sensing
•  Minimal wiring to  
decrease weight
•  Constant monitoring

AEROSPACE 
•   Low temperature 

environment

•  Fit and forget – minimal 

maintenance

•  Stable power sources

INFRASTRUCTURE 
•  Easy to fit beacons
•  Wide temperature range
•  Minimise cost of ownership

MEDICAL 
•  Blood pressure monitoring
•  Neurostimulation
•  Cardiac rhythm management

REVENUE BY GEOGRAPHICAL MARKET

NORTH AMERICA

27.6%

(2017: 18.9%)

UK & EUROPE

70.5%

(2017: 79.1%)

ASIA

1.9%

(2017: 2.0%)

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201804

SUSTAINING THE

ECONOMIC VIABILITY 
OF WIND ENERGY

CASE STUDY

+40%

China and the UK together  
contribute ca. 40 percent 
of the world’s 500 GW wind 
power capacity.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018NEW PARTNERSHIP WITH WIND TURBINE MANUFACTURER IN CHINAIn November 2017, we formed a partnership to deploy Stereax® solid-state battery powered devices for the condition monitoring of wind turbines with Titan Wind Energy, the largest manufacturer of wind turbine products in China.The deployment is part of a two-year collaborative project with Titan Wind Energy, with expert support from the University of Chester and Nanjing University of Aeronautics and Astronautics (‘NUAA’). The £1.0 million development project is supported by Innovate UK funding of £0.4 million. The Chinese partners will receive similar funding from Jiangsu Province.The primary objective of this project is to develop an integrated smart sensor powered by a combined vibration harvester and a Stereax® battery, to be incorporated into the composite structure of wind turbine blades. The smart composite will be able to perform autonomous structural condition monitoring of the blades, to detect the early signs of damage and enable predictability in maintenance scheduling and prevent the icing of the blades. This will ensure operational efficiency, whilst also self-sustaining the power supply of these functionalities without the need for battery replacement.05

We are very excited about 
the opportunity of using 
Ilika’s Stereax® solid-state 
battery technology in the 
globally significant market 
of wind turbine blade 
condition monitoring.

Mr. Ji Jun
President of Titan Wind Energy

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201806

CHIEF EXECUTIVE’S REVIEW
OPERATING REVIEW

Ilika has been working with solid-state battery technology 
since 2008 and has developed a type of lithium-ion battery, 
which, instead of using liquid or polymer electrolyte, 
uses a ceramic ion conductor.

SOLID-STATE BATTERIES
Ilika’s solid-state batteries have a 
number of benefits over lithium-ion 
batteries, including the following:
•  Non-flammable
•  6x faster to charge
•  2x energy density on 

a weight basis

•  10x lower leakage currents

We have continued to 
drive forward our Stereax® 
technology roadmap in 
response to clear customer 
guidance on the commercial 
opportunities it addresses. 
Our three Stereax® 
deployment programmes 
provide us with proof 
points on the differentiated 
properties of our  
technology.

Graeme Purdy
CEO, Ilika

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201807

STEREAX® TECHNOLOGY ROADMAP
Ilika elected to focus its initial cell 
development on miniature devices 
suitable for powering sensors, 
sometimes called IoT end-nodes. 
There are already up to 15 billion 
sensors on the planet and most of 
them are currently either hard-wired 
or powered by disposable coin cells. 
Hard-wired sensors are expensive to 
install because of the cost of cabling, 
but thereafter they have low 
maintenance costs. Sensors powered 
by disposable batteries are relatively 
cheap to install, but expensive to 
maintain because of the cost of the 
maintenance crews deployed to 
replace the batteries at regular 
intervals. Ilika’s miniature devices 
are designed to be combined with 
a small energy harvester (usually PV) 
to allow them to be recharged and 
therefore to operate for an extended 
period of time, usually up to ten 
years. This concept is designed to 
offer a low cost of installation 
compared to hard-wired devices 
combined with lower maintenance 
costs relative to using disposable 
coin cells.

IoT devices offer a different set of 
battery challenges compared to 
other electronic devices. They have 
similar pressures, such as cost and 
availability, but they also have some 
specific requirements:
•  Small size in both footprint and 

thickness

•  Ability to be trickle charged
•  Charged only when an energy 

harvester can get energy

•  Longer life span to match those 

of sensors and MCUs

•  Support wider temperature ranges

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201808

CHIEF EXECUTIVE’S REVIEW
OPERATING REVIEW

In 2016 and 2017, Ilika launched its Stereax® M250 and 
P180 solid-state battery IP respectively. Both devices 
are designed to power IoT devices, with the P180 
being specified to survive exposure to 
higher operating temperatures.

BATTERY PRODUCTS UNDER 
DEVELOPMENT
The Ilika Stereax® roadmap focuses 
on three main areas: 
•  Miniaturisation. This looks at 

progressively smaller footprints, 
down to mm-scale, delivering 
smaller currents (µAh), making 
them ideal for small sensor driven 
devices. The principal commercial 
pull for these batteries is coming 
from the medical device industry, 
accounting for about 50 percent 
of the value of Ilika’s licensing 
pipeline.

BATTERY PRODUCT LAUNCHES 
Relative to other miniature batteries, 
Ilika Stereax® batteries use patented 
materials and processes enabling 
superior energy density per battery 
footprint, up to 40 percent 
improvement on other solid-state 
solutions. Ilika’s batteries do not 
contain any free lithium which makes 
them more moisture resistant. The 
Stereax® M250 operates in a 
temperature range to over 100°C, 
30°C higher than other solid-state 
products. The Stereax® P180 has the 
additional benefit of supporting a 
temperature up to +150°C. This 
higher temperature is required for 
many industrial IoT and automotive 
end applications enabling always on, 
self-charging energy efficient IoT 
solutions for more demanding 
environments. As the trend towards 
digitising industrial processes 
gathers momentum there is a 
growing requirement for 
components with enhanced 
tolerance to temperature, 
moisture and vibration.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201809

•  Capacity. For the launch of both 
the M250 and the P180, Ilika 
designed and made some wireless 
sensor nodes measuring 
temperature, humidity and light 
intensity. The power requirements 
of sensors does vary, depending 
on the nature of the sensor. For 
example, a motion detector has a 
higher power requirement than a 
temperature sensor. In order to be 
able to power a wider range of 
devices, Ilika is increasing the 
energy footprint of its batteries. 
Increasing the amount of energy 
for a given active footprint can be 
achieved by utilising Ilika’s 
patented stacking feature, which 
allows multiple cells to be stacked 
on top of one another. The sector 
most interested in larger capacity 
devices is the industrial IoT and 
this sector accounts for about 
25 percent of the value of the 
licensing pipeline.

•  Large format. Solid-state batteries 

are of great interest to the 
automotive industry. Indeed, Ilika 
first started working on solid-state 
materials through its collaboration 
with Toyota, which commenced in 
2008. Many automotive 
companies now have solid-state 
cells on their electric vehicle 
roadmap and Ilika has experienced 
a rising number of inbound 
enquiries on the possibility of 
scaling its technology to address 
the opportunity to use solid-state 
as a motive power battery. This 
topic is discussed further below.

E
N
E
R
G
Y
D
E
N
S

I

T
Y

,

P
E
R
F
O
R
M
A
N
C
E

Goliath 1Ah

LARGE FORMAT

PERFORMANCE

CAPACITY

Stereax® P180 Extended 
temp performance
(-40°c to +150°c)

SSB integrated 
with solar panel

High energy

MINIATURISATION

High-energy 
mm-scale

mm-scale

Stereax® M250 
250 μAh, 1cm2

FUTURE

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018 
 
10

SOLID-STATE BATTERY

ADVANTAGES FOR 
MEDICAL DEVICES

CASE STUDY

This partnership may provide 
the potential to treat diseases 
that have so far been difficult 
to manage. Collaborations 
like this are critical to the 
delivery of advances in 
the field of solid-state 
battery development.

Graeme Purdy
CEO, Ilika

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018ILIKA HAS A TWO-YEAR COLLABORATIVE PROJECT WITH A BIOELECTRONICS COMPANY TO DEVELOP A SOLID-STATE BATTERY FOR MINIATURE MEDICAL IMPLANTSIlika’s Stereax® batteries have a high power density, a long battery life and they can be produced in miniature form, making them particularly suitable for these micro-devices.This collaboration aims to deliver key components of bioelectronic devices, which have the potential to provide treatments for serious health conditions, through the body’s own nervous system.The £1.0 million development project is supported by funding of £0.7 million,  which Ilika will receive from Innovate UK and the Medical  Research Council.11

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201812

CHIEF EXECUTIVE’S REVIEW
BUSINESS STRATEGY

The Company’s mission is to have its Stereax® solid-state 
batteries integrated into market-leading products sold by 
leading commercialisation partners around the world. 

automated processes to 
simultaneously deposit large arrays 
of systematically varying materials, 
which can be rapidly evaluated to 
determine their functional properties. 
In addition to the Stereax® product 
development and commercialisation 
work, the Company executes a small 
portfolio of programmes with large 
multinational companies to develop 
materials for the automotive, 
aerospace and electronic sectors. 

BUSINESS STRATEGY
The Company generally expects 
these end-products to fit into or 
create end-markets worth in excess 
of $1 billion per year, in which the 
Directors believe a number of 
the Company’s commercialisation 
partners are positioned to have a 
leading share.

The Company’s revenue model 
involves three phases of activity:
a)  commercially-funded and grant-
funded development projects;

b) IP licensing; and 
c)  receipt of royalties when products 
incorporating Ilika IP reach market. 
Ilika is currently in the first phase 
of activity, with its revenue being 
generated from a portfolio of 
development programmes. The 
Company has built a pipeline of 
licensing opportunities to support 
the start of its second phase of 
revenue generation.

The Company has developed its 
Stereax® batteries using its high 
throughput materials innovation 
platform. This platform uses 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201813

b
u
k

l

Goliath Pouch
cell Stereax®

Thin film
Stereax®

S
C
A
L
E

Solid electrolyte
materials with
Toyota

OUR BUSINESS MODEL 
•  Advanced solid-state 
technology developer 

•  Business model to potentially 
yield high margins over time 
–  Upfront licence fee from 
flexible licensing models 
–  Ongoing royalties, based 

on a percentage of system 
volume shipped 

–  Technology deployed across 

multiple applications 
•  Long-term, global growth  

markets 

i

i

m
n
a
t
u
r
e

High  
throughput  
screening

commercial

COMMERCIAL READINESS

development

R&D 
costs
$

Development 
revenue
$

Licence
revenue
$

Royalty
revenue
$

Customers: semi, MEMS, battery, 
multiple sector OEMs

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 20183-4 YEARSIlika R&D2-3YEARSPartner system development+20 YEARSMultiple applications development and sales14

DELIVERING THE BENEFITS OF

SOLID-STATE BATTERIES 
FOR ELECTRIC VEHICLES

CASE STUDY

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018ILIKA HAS EXTENDED ITS STEREAX® ROADMAP TO INCLUDE LARGE FORMAT SOLID-STATE BATTERIES (CODENAMED GOLIATH) SUITABLE FOR AUTOMOTIVE TRACTION BATTERIESIt has received offers of grant funding to support its participation in two development projects selected by the Faraday Challenge competition worth up to £4.2 million in aggregate to Ilika. Participation in both projects is subject to contract and certain other conditions being met.Ilika is the lead partner in the PowerDrive Line project, in which it intends to collaborate with Honda, Ricardo, the Centre for Process Innovation (‘CPI’) and University College London. The proposed project grant funding for all partners is £4.4 million, of which Ilika will receive £2.3 million. This 30-month collaborative project will develop a lithium-based solid-state Stereax® battery for plug-in hybrid and electric vehicles, establish a pre-pilot line for solid-state battery cell technology and develop processes for a solid-state materials supply chain. The innovative solid-state technology will enable safer, more energy and power dense cells that will facilitate ultra-fast charging, enabling plug-in hybrid electric vehicle (‘PHEV’) or battery electric vehicle (‘BEV’) drivers to charge their cars in under 25 minutes.15

Effective, efficient and sustainable 
transport is key to addressing so many 
of today’s challenges from industrial 
growth to social inclusion. Through 
advanced battery technology, we will 
unlock a new generation of electric 
vehicles, further improving vehicle 
performance and uptake, opening doors 
to innovative new transport ideas and 
significantly reducing environmental 
impacts. Today’s investment shows we 
are catalysing collaboration between 
research teams and commercial 
partners across the UK to make 
this a reality.

Professor Sir Mark Walport
UK Research and Innovation 
Chief Executive

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201816

CHIEF EXECUTIVE’S REVIEW
BUSINESS STRATEGY

STEREAX® DEVELOPMENT AND 
DEPLOYMENT PROJECTS

Ilika has secured three development 
and deployment programmes with 
global OEMs: 

INTEGRATED ENERGY HARVESTER 
AND BATTERY
In December 2016, the Company 
announced a two-year collaborative 
project with Sharp Laboratories of 
Europe (now known as Lightricity) 
to create an autonomous energy 
harvesting power source which will 
involve the integration of Ilika’s 
solid-state battery with Lightricity’s 
PV technology creating the world’s 
first fully integrated thin-film power 
source. This integration project is 
aligned with the development track 
for increasing the capacity of 
Stereax® batteries.

MINIATURE MEDICAL IMPLANT
In March 2017, the Company 
announced a two-year collaborative 
project with a well-financed 
bioelectronics company to develop 
a battery for miniature medical 
implants to provide treatments for 
serious health conditions, through 
the body’s own nervous system. 
The programme is supported by 
Innovate UK and the Medical 
Research Council.

WIND TURBINE CONDITION 
MONITORING
In November 2017, Ilika announced 
a partnership to deploy Stereax® 
powered devices for the condition 
monitoring of wind turbines with 
Titan Wind Energy, the largest 
manufacturer of wind turbines in 
China and the fourth largest globally.

INNOVATE UK FARADAY CHALLENGE
Innovate UK is expecting 50 percent 
of vehicle production by 2030 to be 
BEV or PHEV. In July 2017, the UK 
government announced a £246 
million commitment over four years 
for automotive battery development, 
covering cell manufacture, modules, 
battery pack design and deployment 
in vehicles. In November 2017, this 
was followed with the announcement 
of an £80 million National Battery 
Manufacturing Development Facility 
in Warwick. Innovate UK is 
administering a series of 
competitions, designed to promote 
battery innovation. In a post year 
end development in June 2018, Ilika 
announced that it has been offered 
£4.1 million of grant funding to 
participate in collaborations with 
Honda, Ricardo, McLaren and 
A123 Batteries.

The development of large format 
cells will require Ilika to build a lower 
cost printing platform, suitable for 
printing bulk materials. This will 
involve establishing a pre-pilot line 
at its facility in Southampton. It is 
anticipated that a second stage of 
scale-up to a pilot line could be 
achieved in collaboration with the 
National Battery Facility. Ilika 
currently expects to use its licensing 
model to commercialise the large 
format cells in the same way it is 
bringing its miniature batteries 
to market.

PATENT POSITION
Building Ilika’s intellectual property 
portfolio in solid-state batteries has 
continued to be a focus this year. 
Three additional filings relating to 
solid-state batteries were made, 
covering electrolyte and electrode 
compositions as well as processing 
methods for singulating cells. In 
addition, three filings were made 
covering new super-elastic and 
high-strength alloys from our 
self-healing alloy project. During the 
course of the year, three patents 
went to grant in the USA covering 
core-shell catalysts for fuel cells. 
These patents cover catalysts that 
are stable in the aggressive acidic 
environment of hydrogen fuel cells, 
while being active in the promotion 
of the chemical reactions necessary 
for converting hydrogen and oxygen 
into water. Ilika now maintains a 
portfolio of 22 patent families, 
comprising of 81 patents.

MATERIALS PORTFOLIO ACTIVITIES
While the Company’s strategy has 
been to focus the majority of its 
resources on developing and 
commercialising its solid-state 
battery technology, Ilika was also 
active in the development of other 
energy materials, aerospace alloys 
and materials for electronics 
applications using its high 
throughput platform.

ENERGY MATERIALS
In August 2016, Ilika announced that 
it is taking part in a three-year 
project to develop protected anodes 
for lithium sulphur batteries, led by 
Johnson Matthey Plc. This project is 
developing an innovative protected 
lithium anode approach to discover 
new electrolyte composition options 
and fabricate a free-standing, 
lithium-containing protected anode/
separator for integration into pouch 
cells. The novel protected anode will 
mitigate a commonly experienced 
problem in lithium sulphur cells, the 
so-called polysulphide shuttle effect, 
leading to enhanced performance 
cells that can be made with existing 
cell fabrication methods. The pouch 
cells being developed in this project 
are high capacity, low cost batteries 
for large scale renewable energy 
storage and therefore address a 
distinct market segment to the 
applications for which Ilika’s Stereax® 
batteries are designed. This project 
will complete in 2019.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201817

In January 2018, Ilika completed its 
role leading a three-year Innovate 
UK funded project with Rolls-Royce, 
Diamond Light Source and the 
University of Cambridge to develop 
new superalloy compositions for gas 
turbine engines with better thermo 
efficiency than current alloys. The 
alloys are designed to increase gas 
turbine performance, reducing CO2 
emissions and noise levels at take-off.

ELECTRONIC MATERIALS
Ilika has continued its collaboration 
with Seagate, developing materials 
and processes for Hard Disk Drive 
(‘HDD’) applications. The project is 
focused on materials with superior 
nanophotonic properties to achieve 
improved hard drive performance 
and reliability. These materials must 
operate at temperatures of up to 
300°C for thousands of hours, 
requiring extremely robust 
nanomaterials that have specific 
photonic properties allowing light 
energy to be conducted.

In March 2018, Ilika announced 
an 18-month collaboration with 
PragmatIC and Arm to further 
progress development of ultra-thin 
and flexible semiconductors for mass 
market applications. The principal 
objective is to deliver P-type 
metal-oxide semiconductor circuit 
technology to enhance PragmatIC’s 
flexible integrated circuit designs. 
The first application is the smart 
packaging market which is predicted 
to grow at a CAGR of 8 percent to 
a projected value of $7.8 billion 
by 2021.

QUALITY MANAGEMENT SYSTEM
In January 2018, Ilika announced 
that its quality management system 
(‘QMS’) for the development of 
solid-state batteries and materials 
R&D programmes has been 
assessed and found to meet the 
requirements of ISO 9001:2015 by 
DAS certification. ISO 9001 is the 
world’s most widely recognised 
QMS and helps organisations to 
meet the expectations and needs 
of their customers. The certification 
promotes the development of 
continual improvement, customer 
satisfaction, traceability and 
international best practices. Ilika 
aims to provide clients with the 
highest quality services and the ISO 
certification means that clients can 
have increased confidence in the 
service provided. The certification 
is independently audited annually.

KEY PERFORMANCE INDICATORS 
(‘KPIS’)
The Board considers that the most 
important KPIs are technical and 
operational and relate to the sales 
pipeline and engagement of 
commercialisation partners resulting 
from the progress of the technical 
development programmes 
outlined above.

The most important financial 
KPIs are the cash position and the 
operating loss of the Group, which 
remain under constant focus and 
which are considered in the 
financial review.

In March 2017, Ilika announced a 
$1 million, one year commercially-
funded programme with the Toyota 
Research Institute (‘TRI’) to develop 
game changing energy materials. 
The programme is part of a $35 
million investment by TRI over four 
years in research that uses artificial 
intelligence to accelerate the design 
and discovery of advanced materials. 
In this initial collaboration with the 
Company, Ilika’s unique high-
throughput platform was used to 
make and test candidate materials, 
which were identified using 
simulation, machine learning and 
artificial intelligence strategies. 
Ilika has now completed the initial 
screening activities associated with 
this phase of the project. Promising 
materials will be further scaled-up 
by Toyota and its suppliers for 
deployment in its future low-
emission vehicles. 

AEROSPACE ALLOYS
Ilika has continued in its lead role in a 
£2.15 million, three-year Innovate UK 
grant funded project with BAE 
Systems, GKN, Reliance Precision 
Engineering and the University of 
Sheffield. The project started in 
September 2015 to develop a new 
generation of self-healing alloys 
suitable for additive manufacturing 
(‘AM’) processes and to develop a 
metallic manufacturing process that 
takes advantage of the flexibility of 
AM and the precision of subtractive 
manufacturing. This will enable the 
manufacture of novel components 
with critical feature tolerances, 
meeting the challenges faced in 
the design of mechanisms for the 
aerospace industry with lower 
weight, structural integrity and 
functional performance. The 
programme has been productive in 
defining new alloy systems of interest 
and a series of patent filings have 
been made.

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201818

RAPIDLY DEVELOPING

NOVEL THIN-FILM 
MATERIALS & DEVICES

CASE STUDY

The project focuses on investigating 
the operating parameters of PMOS,  
using Ilika’s high throughput 
thin-film techniques which are 
proven for rapid identification and 
screening of functional thin-film 
materials. The initial phase of the 
project is intended to demonstrate 
the innovative thin film transistor 
performance, which is to be followed 
by scale-up and transfer of the 
material to deposition processes 
in a production environment.

This collaboration is 
a strong fit with our 
technology capability in 
rapidly developing novel 
thin-film materials and 
devices. A successful 
outcome would 
enable the collaboration 
partners to address large 
global markets in this 
disruptive sector.

Graeme Purdy
CEO, Ilika

$7.8BN

The first application for these 
flexible ICs is the smart packaging 
market which is predicted to grow 
to a projected value of $7.8 billion 
by 2021.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018TECHNICAL COLLABORATION WITH PRAGMATIC AND ARM HOLDINGSIn March 2018, we formed a collaboration with PragmatIC and Arm Holdings (‘Arm’) to further progress development in ultra-thin and flexible semiconductor technology for mass market applications.The 18-month project is supported by Innovate UK funding of £0.6 million of which £0.4 million will be payable to Ilika.The principal objective of this collaboration is to deliver novel P-type metal-oxide semiconductor (‘PMOS’) circuit technology that can significantly enhance the characteristics of PragmatIC’s CMOS designs. 19

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201820

FINANCIAL REVIEW

STATEMENT OF FINANCIAL POSITION 
AND CASH FLOWS
At 30 April 2018, net assets 
amounted to £3.8 million (2017: 
£6.2 million), including net funds 
of £2.8 million (2017: £5.4 million).

The principal elements of the 
£2.6 million decrease over the year 
ended 30 April 2018 in net funds 
were:
•  Cash used in operations of 

£2.6 million (2017: £3.2 million);
•  Purchase of plant, property and 

equipment of £0.3 million 
(2017: £0.3 million); and

•  R&D tax credits received of 

£0.4 million (2017: £0.4 million).

ADMINISTRATIVE EXPENSES AND 
LOSSES FOR THE PERIOD
Administrative costs for the year 
were slightly decreased at £3.8 
million in 2018 relative to £3.9 million 
in 2017. This excludes the share-
based payment charge.

Combined cost of sales and 
administrative expenses were 
£4.9 million in the year which is up 
from the £4.4 million for 2017 and is 
associated with the increased level 
of commercial and grant supported 
programmes.

2,173,210 Options lapsed in the year, 
of which 1,386,650 lapsed due to 
performance criteria. No reduction 
has been made in the share-based 
payment charge in respect of these 
lapsed options. 1,266,117 options were 
granted in the period. 

The lower share-based payment 
charge together with the improved 
margin meant that loss on continuing 
activities before tax reduced from 
£3.9 million in 2017 to £3.3 million 
in 2018. 

The Financial Review should be read 
in conjunction with the consolidated 
financial statements of the Company 
and Ilika Technologies Limited 
(together the ‘Group’) and the notes 
thereto on pages 38 to 49. The 
consolidated financial statements 
are presented under International 
Financial Reporting Standards as 
adopted by the European Union. 
The financial statements of the 
Company continue to be prepared 
in accordance with International 
Financial Reporting Standards as 
adopted by the European Union 
and are set out on pages 50 to 54.

STATEMENT OF COMPREHENSIVE 
INCOME

REVENUES
Revenue, all from continuing 
activities, for the year ended 
30 April 2018 was £2.1 million (2017: 
£1.1 million). This includes £1.3 million 
of grant income recognised from 
nine projects that the Company has 
in progress with Innovate UK (2017: 
£0.7 million from six programmes). 
Details of the various programmes 
are provided in the Materials 
Portfolio activities on page 16. 

More of the Company’s activities are 
supported by grant or commercial 
funding than was the case in the 
prior year, where operational 
resources were more heavily devoted 
to the internally funded battery 
development programme. 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201821

PRINCIPAL RISKS AND UNCERTAINTIES

COMMERCIAL RISK

The Group is subject to competition from competitors who may 
develop more advanced and less expensive alternative technology 
platforms, both for existing materials and for those materials currently 
under development. The Group is largely dependent on its partners to 
commercialise the end-products containing the Group’s materials.

The Group seeks to reduce this risk by continually assessing competitive 
technologies and competitors. The Group seeks to commercialise 
materials through multiple channels to reduce over-reliance on 
individual partners and, in agreements with partners, it ensures that 
there are commercialisation milestones which must be met for the 
partner to retain the rights to commercialise the materials.

FINANCIAL RISK

The Group is reliant on a small number of significant customers and partners. 
Termination of these agreements could have a material adverse effect on the 
Group’s results or operations or financial condition. The Group expects to incur 
further operating losses as progress on development programmes continue. 

The Group seeks to reduce this risk by broadening the number 
of customers and partners and thereby reduce reliance on 
individual significant companies. The Group applies for R&D tax 
credits to help mitigate its investment in these activities. 

INTELLECTUAL  
PROPERTY RISK

The Group faces the risk that intellectual property rights necessary 
to exploit R&D efforts may not be adequately secured or defended. 
The Group’s intellectual property may also become obsolete before 
the products and services can be fully commercialised.

The Group seeks to reduce this risk by employing in-house staff with extensive 
global experience of patenting and licensing using commercially available 
patent searching and landscaping software. External patent agents and 
attorneys are used to advise on the drafting and filing of patent applications.

DEPENDENCE ON 
SENIOR MANAGEMENT 
AND KEY STAFF

Certain members of staff are considered vital to the successful 
development of the business. Failure to continue to attract and retain 
such highly skilled individuals could adversely affect operational results.

The Group seeks to reduce this risk by offering appropriate 
incentives to staff through competitive salary packages and 
participation in long-term share option schemes.

BREXIT RISK

The Group has reviewed the potential impact of Brexit on the risks 
identified above and believes that whilst intellectual property risk will 
remain largely unaffected, there may be an impact in the future regarding 
the Group’s ability to attract and retain highly skilled individuals. 

The Group is alert to and continuously reviewing this potential 
risk and formulating its response at the appropriate time.

By order of the Board

Mike Inglis 
Chairman 
10 July 2018

Graeme Purdy
CEO

WWW.ILIKA.COM

STRATEGIC REPORTCORPORATE GOVERNANCEFINANCIAL STATEMENTSILIKA PLC ANNUAL REPORT AND ACCOUNTS 201822

BOARD OF DIRECTORS

MIKE INGLIS
Chairman (independent) 

GRAEME PURDY
Chief Executive Officer 

PROF. BRIAN HAYDEN
Chief Scientific Officer 

STEPHEN BOYDELL
Finance Director 

Graeme was appointed 
to head-up Ilika from the 
beginning of May 2004, 
just before completion 
of the Company’s seed 
round of funding. He led 
the Company through two 
successful rounds of venture 
funding before floating the 
Company on AIM in 2010.

Prior to joining Ilika, Graeme 
was Chief Operating Officer of 
a high-technology company 
in the Netherlands and before 
that worked internationally 
in a variety of technical and 
commercial roles for Shell. 
Graeme holds a Master’s 
degree in Chemical Engineering 
from Cambridge and an 
MBA from INSEAD business 
school in France. Graeme is 
a Chartered Engineer and a 
Sainsbury Management Fellow.

Brian is a founder of Ilika and 
holds the Executive role of 
Chief Scientific Officer. He 
is also professor of Physical 
Chemistry at the University of 
Southampton, a Fellow of the 
Royal Society of Chemistry, 
Fellow of the Institute of 
Physics and a member of 
the International Editorial 
Board of Surface Science. 

Brian is a pioneer of surface 
science with a strong track 
record in running successful 
industrial collaborations 
and has published in excess 
of 100 papers in the fields 
of surface science, surface 
electrochemistry and 
fundamental aspects of 
heterogeneous catalysis 
and electro-catalysis. 

He is also the author of over 12 
active patents, including new 
catalysts and materials for 
low-temperature fuel cells and 
solid-state lithium-ion batteries.

Having qualified with Deloittes 
in 1996, Stephen held a number 
of acquisition, treasury and 
Group reporting roles at 
both Hays plc, a diversified 
commercial, logistics and 
personnel group, and then 
AGI Media, a global creative 
packaging group. He then 
become Finance Director of 
Healthy Direct, a successful 
Guernsey-based group of 
companies, producing and 
supplying vitamins and 
supplements to the UK market. 
He was instrumental in the 
restructuring of that Group 
and its subsequent trade sale 
to a competitor. He joined Ilika 
in 2009 as Finance Director 
and Company Secretary.

Stephen studied Economics 
at Nottingham University and 
is a Fellow of the Institute of 
Chartered Accountants.

Mike Inglis was appointed a 
Non-Executive Director of Ilika 
in July 2015 and Chairman in 
September 2015. He is currently 
a Non-Executive Director of 
Advanced Micro Devices Inc 
and as of 1 September 2015 of 
BT plc. Mike is also a member of 
the BT Technology Committee.

Formerly, Mike was a Director 
and member of the Executive 
of Arm Holdings for over 
a decade, serving as Chief 
Commercial Officer until the 
end of March 2013, having 
previously been EVP & GM 
Processor Division and EVP 
Sales and Marketing. Before 
joining Arm, he worked in 
management consultancy 
with AT Kearney and held a 
number of senior operational 
and marketing positions at 
Motorola. Mike has previously 
worked in semi-conductor 
sales, marketing, engineering 
and consultancy with Texas 
Instruments, Fairchild and BIS 
Macintosh and gained his initial 
industrial experience with GEC 
Telecommunications. He is a 
Chartered Engineer and  
a Chartered Marketer.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201823

CLARE SPOTTISWOODE CBE
Non-Executive Director 

PROF. SIR WILLIAM 
WAKEHAM
Non-Executive Director

PROF. KEITH JACKSON
Non-Executive Director 

Clare’s career started as an 
economist with the Treasury 
before establishing her 
own software company.

She is perhaps best known 
for her role as Director 
General of Ofgas between 
1993 and 1998, where she 
oversaw the transformation 
of the gas industry from a 
monopoly, which controlled 
the whole gas supply 
chain, into a deregulated, 
competitive industry. 

Clare was a commissioner on 
the Independent Commission 
on Banking Chaired by John 
Vickers, and currently chairs 
Gas Strategies Group Limited 
and Flowgroup plc. She is 
also a Non-Executive Director 
of G4S plc and EnQuest plc. 
Awarded a CBE for services 
to industry in 1999, she holds 
degrees from Cambridge and 
Yale Universities and  
has an honorary doctorate 
from Brunel.

Prof. Sir William Wakeham 
retired as Vice-Chancellor of 
the University of Southampton 
in September 2009. He studied 
Physics at Exeter University 
at both undergraduate 
and doctoral level. 

He is a Fellow, Senior Vice-
President and International 
Secretary of the Royal 
Academy of Engineering, 
a Fellow of the Institution 
of Chemical Engineers, the 
Institution of Engineering and 
Technology, the Institute of 
Physics and the Portuguese 
Academy of Engineering. He is 
a Visiting Professor at Imperial 
College London, Exeter and 
Lisbon, Chair of Exeter Science 
Park Limited and Trustee of 
Royal Anniversary Trust.

He was knighted in 
2009 for services to 
Chemical Engineering 
and Higher Education.

Keith has had a wide-ranging 
and successful career in 
companies varying from 
start-ups to multinationals. 
He founded and grew an 
automotive control systems 
company whose engine 
control systems are used on 
millions of vehicles around the 
world. Following the sale of 
the Company to a major car 
company he joined Rolls-
Royce plc, where he worked 
as Chief Technology Officer 
in the electrical power and 
control systems group. 

Keith is Chief Technology 
Officer at Meggitt PLC, 
a global aerospace and 
energy components and 
systems company, where 
he is responsible for the 
technology strategy and 
research and technology. He 
is also actively involved on 
talent development at Meggitt 
through its Fellowship and 
graduate programmes.

Keith is a Fellow of the Society 
of Automotive Engineers, 
a Rolls-Royce Engineering 
Fellow and a visiting Professor 
at Sheffield University. 
He is a graduate from 
University College London.

WWW.ILIKA.COM
WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT24

DIRECTORS’ REPORT

DIRECTORS 
The Directors who served on the Board of Ilika during 
the year and to the date of this report were as follows:

Between 30 April 2018 and the date of this report, there 
has been no change in the interests of Directors in shares 
as disclosed in this report.

EXECUTIVE
Mr. S. Boydell (FD and Company Secretary) 
Prof. B. E. Hayden (CSO) 
Mr. G. Purdy (CEO) 

SUBSTANTIAL SHAREHOLDINGS
On 2 July 2018 the Company had been notified of the 
following holdings of more than 3 percent or more of 
the issued Share capital of the Company.

NON-EXECUTIVE
Mr. M. Inglis (Chairman)
Ms. C. Spottiswoode CBE 
Prof. Sir W. Wakeham (Senior Independent Director)
Prof. K. Jackson 

R&D COSTS
In accordance with the policy outlined in note 1, the 
Group incurred R&D expenditure of £2,009,023 in 
the year (2017: £2,110,843). Commentary on the major 
activities is given in the Strategic Report. 

FINANCIAL INSTRUMENTS
The use of financial instruments and financial risk 
management policies is covered in the Strategic 
Report and also in note 13 of the financial statements.

FUTURE DEVELOPMENTS
Information on the future developments of the business 
are included in the Strategic Report on page 2.

DIVIDENDS
The Directors do not recommend the payment of a 
dividend.

DIRECTORS’ INTERESTS IN ORDINARY SHARES
The Directors, who held office at 30 April 2018, had 
the following interests in the Ordinary Shares of the 
Company:

Shareholder

Sapia Partners
Henderson Global
Hargreave Hale
Parkwalk Advisors
Charles Stanley Group plc
Baillie Gifford & Co.
Southampton 

Asset Management

Number of 
Ordinary Shares

Percent 
shareholding

11,374,800
11,300,000
8,326,220
5,300,000
4,763,216
4,643,978

2,349,900

14.5
14.4
10.6
6.8
6.1
5.9

3.0

POST BALANCE SHEET EVENTS
There are no significant post balance sheet events from 
30 April 2018 to the signing of this report.

AUDITORS
All the current Directors have taken all the steps that they 
ought to have taken to make themselves aware of any 
information needed by the Company’s Auditors for the 
purposes of their audit and to establish that the Auditors 
are aware of that information. The Directors are not aware 
of any relevant audit information of which the Auditors 
are unaware.

A resolution to re-appoint BDO LLP will be proposed at 
the next Annual General Meeting. 

By order of the Board

Number of Shares

1 May 2017

30 April 2018

Steve Boydell
Company Secretary

G. Purdy
C. Spottiswoode
S. Boydell
M. Inglis
W. Wakeham
K. Jackson
B. Hayden1

609,427
45,454
9,090
115,000
20,000
20,000
–

609,427
45,454
9,090
115,000
20,000
20,000
–

1  B. Hayden had an interest in Preference Shares of the Company amounting to 

426,300 at 1 May 2017 and at 30 April 2018.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201825

DIRECTORS’ REMUNERATION REPORT

REMUNERATION COMMITTEE
The Group’s remuneration policy is the responsibility 
of the Remuneration Committee (the ‘Committee’). 
The terms of reference of the Committee are outlined 
in the Corporate Governance Statement on page 29.  
The Committee members are Mike Inglis (Chairman), 
Clare Spottiswoode, Prof. Keith Jackson and Prof. 
Sir William Wakeham, all of whom are independent 
Non-Executive Directors.

The Chief Executive Officer and certain executives may 
be invited to attend Committee meetings to assist with its 
deliberations, but no executive is present when their own 
remuneration is being discussed. 

REMUNERATION POLICY

(I) EXECUTIVE REMUNERATION
The Committee has a duty to establish a remuneration 
policy which will enable it to attract and retain individuals 
of the highest calibre to run the Group. Its policy is to 
ensure that the executive remuneration packages of 
Executive Directors and the fee of the Chairman are 
appropriate given performance, scale of responsibility, 
experience, and consideration of the remuneration 
packages for similar executive positions in companies 
it considers to be comparable. Packages are structured 
to motivate executives to achieve the highest level of 
performance in line with the best interests of 
shareholders. A significant proportion of the total 
remuneration package, in the form of bonus and share 
options, is performance driven and has been constructed 
following consultation with major shareholders.

COMPONENTS OF REMUNERATION

Component

Base salary

Purpose and link to strategy

Operation

Performance metrics

To attract and retain 
talent.

Reflecting individual’s role, 
experience and performance. 
Base salaries are reviewed 
annually in January.

Take into account Group 
and individual performance, 
external benchmark 
information and internal 
relativities.

Benefits and Pension

To offer market 
competitive package.

Short-Term Incentive 
Plan – annual 
performance-related 
bonus

Rewards the 
achievement of 
short-term financial 
and strategic project 
milestones.

Long-Term Incentive 
Plan – restricted share 
unit awards

Incentivise, retain and 
reward the Executive 
Directors for successfully 
taking the Company 
through the next stage 
of its growth.

Shareholding  
guidelines

To increase shareholder 
alignment.

Contribution to the Executive 
Director’s individual money 
purchase scheme (at between 
8 percent and 10 percent of base 
salary) and critical illness cover.

n/a

Maximum bonus of base salary: 
100 percent CEO, 60 percent 
CSO and 40 percent CFO. 
50 percent of the bonus is 
payable in cash and 50 percent 
is deferred into shares (using 
nominal cost options) for one 
year, subject to continued 
employment.

Ilika plc Long-Term Incentive Plan 
2015 (the ‘LTIP’), was adopted by 
shareholders at the 2015 AGM
Single awards of share options 
with an exercise price of the 
nominal value of the shares 
were made which will vest 
after three years.

100 percent of the net of tax 
share awards which vest must 
be retained until the following 
guidelines are met:
CEO 300 percent of salary.

Delivery of exceptional 
performance against 
a series of financial, 
commercial and 
technology objectives.

Awards vest to the extent 
that challenging share price 
targets have been met.

n/a

WWW.ILIKA.COM
WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT26

DIRECTORS’ REMUNERATION REPORT

(II) CHAIRMAN AND NON-EXECUTIVE DIRECTOR 
REMUNERATION
The Chairman, Mr. Inglis receives a fixed fee of £65,975 
per annum. Clare Spottiswoode, Prof. Sir William 
Wakeham and Prof. Keith Jackson received a fixed fee 
of £32,988 per annum. The fixed fee covers preparation 
for and attendance at meetings of the full Board and 
committees thereof. The Chairman and the Executive 
Directors are responsible for setting the level of non-
executive remuneration. The Non-Executive Directors are 
also reimbursed for all reasonable expenses incurred in 
attending meetings.

All remuneration policies will be reviewed regularly to 
maintain adherence with best market practice as 
appropriate.

DIRECTORS’ REMUNERATION
The aggregate remuneration received by Directors who 
served during the year ended 30 April 2018 and 30 April 
2017 was as follows:

Year to 30 April 2018
G. Purdy
S. Boydell
B. Hayden1
M. Inglis
K. Jackson
W. Wakeham
C. Spottiswoode

Year to 30 April 2017
G. Purdy
S. Boydell
B. Hayden1
M. Inglis
J. Boyer
K. Jackson
W. Wakeham
C. Spottiswoode

Basic 
salary
£

Benefits- 
in-kind
£

193,000
125,405
64,960
65,975
32,988
32,988
32,988

548,304

191,000
123,429
64,320
65,325
32,662
32,662
32,662

622
405
–
–
–
–
–

1,027

615
399
–
–
–
–
–

Bonus
£

25,502
6,630
8,144
–
–
–
–

40,276

50,250
13,043
19,372
–
–
–
–

Total
short-term 
benefits
£

219,124
132,440
73,104
65,975
32,988
32,988
32,988

589,607

241,865
136,871
83,692
65,325
32,662
32,662
32,662

Pension
£

Total
£

30,300
17,592
–
–
–
–
–

47,892

30,100
17,434
–
–
–
–
–

249,424
150,032
73,104
65,975
32,988
32,988
32,988

637,499

271,965
154,305
83,692
65,325
32,662
32,662
32,662

542,060

1,014

82,665

625,739

47,534

673,273

1  B. Hayden is employed by the University of Southampton. The amounts disclosed in the table above relate to payments made directly to B. Hayden. The University of 

Southampton recharged employment costs of £68,544 to the Company in the year in respect of B. Hayden. (2017: £67,313).

Benefits-in-kind include critical illness cover.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201827

SHARE OPTIONS
The Share options of the Directors are set out below:

Unapproved
G. Purdy1
G. Purdy
G. Purdy2
G. Purdy
B. Hayden1
B. Hayden
B. Hayden1
B. Hayden2
B. Hayden
S. Boydell
S. Boydell2
S. Boydell
W. Wakeham
C. Spottiswoode
M. Inglis3
K. Jackson3

Approved
G. Purdy1
G. Purdy1
S. Boydell
S. Boydell1

2017
Number 

2018
Number

Exercise  

price

Expiry  
date

Performance 
conditions

136,200
1,050,000
872,727
– 
59,300
525,000
177,900
527,272
–
117,600
274,909
–
65,100
50,100
120,000
40,000

26,500
245,300
90,000
154,600

–
1,050,000
872,727
145,810
–
525,000
–
527,272
56,211
117,600
274,909
37,846
65,100
50,100
120,000
40,000

–
–
90,000
–

80p
51p
1p
1p
80p
51p
81.5p
1p
1p
51p
1p
1p
51p
51p
68.75p
68.75p

80p
81.5p
80p
81.5p

 July 2017
May 2020
September 2025
August 2027
 July 2017
May 2020
–
September 2025
August 2027
May 2020
September 2025
August 2027
May 2020
May 2020
September 2025
September 2025

May 2017
–
December 2019
–

n/a
n/a
See note 4
n/a
n/a
n/a
See note 4
See note 4
n/a
n/a
See note 4
n/a
n/a
n/a
See note 4
See note 4

n/a
See note 4
n/a
See note 4

1  Share options lapsed in the year.
2  Shareholders’ approval to adopt and establish the Ilika plc Long-Term Incentive Plan 2015 (the ‘LTIP’) was received at the AGM in September 2015. 
3  Shareholders’ approval to grant unapproved share options to the Non-Executive Directors Mike Inglis and Professor Keith Jackson was received at 

the AGM in September 2015.

4  These awards will vest on the achievement of the following share price targets, assessed over a three year performance period:

(a) Less than 50 percent growth in share price – no vesting.
(b) 50 percent growth in share price – 25 percent of the shares subject to award will vest.
(c) 100 percent growth in share price – 75 percent of the shares subject to award will vest.
(d) 200 percent growth in share price – 100 percent of the shares subject to award will vest.
  Awards will vest between points (b) and (c) and between (c) and (d) on a straight-line basis.

Share-based payment charge attributable to directors in the year was £409,502 (2017: £428,587).

During the year, the Committee received independent advice on executive remuneration matters from 
FIT Remuneration Consultants LLP. FIT received £7,380 in fees for these services. 

Mike Inglis
Chairman of the Remuneration Committee

WWW.ILIKA.COM
WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT 
 
 
 
28

STATEMENT OF DIRECTORS’ RESPONSIBILITIES
IN RESPECT OF THE ANNUAL REPORT AND THE FINANCIAL STATEMENTS

WEBSITE PUBLICATION
The Directors are responsible for ensuring the Annual 
Report and the financial statements are made available 
on a website. Financial statements are published on 
the Group’s website in accordance with legislation in 
the United Kingdom governing the preparation and 
dissemination of financial statements, which may vary 
from legislation in other jurisdictions. The maintenance 
and integrity of the Group’s website is the responsibility 
of the Directors. The Directors’ responsibility also extends 
to the ongoing integrity of the financial statements 
contained therein.

GOING CONCERN
The Directors have prepared and reviewed financial 
forecasts. After due consideration of these forecasts and 
current cash resources, the Directors consider that the 
Company and the Group have adequate financial 
resources to continue in operational existence for the 
foreseeable future (being a period of at least 12 months 
from the date of this report), and for this reason the 
financial statements have been prepared on a going 
concern basis. Following the signing of the financial 
statements the Directors anticipate raising additional 
funds from the issue of shares to assist in the financing 
of the Group’s operations.

By order of the Board

Graeme Purdy
Chief Executive
10 July 2018

The Directors are responsible for preparing the Annual 
Report and the financial statements in accordance with 
applicable law and regulations. 

Company law requires the Directors to prepare financial 
statements for each financial year. Under that law the 
Directors have elected to prepare the Group and 
Company financial statements in accordance with 
International Financial Reporting Standards (‘IFRSs’) as 
adopted by the European Union. Under company law 
the Directors must not approve the financial statements 
unless they are satisfied that they give a true and fair 
view of the state of affairs of the Group and Company 
and of the profit or loss of the Group and Company for 
that period. The Directors are also required to prepare 
financial statements in accordance with the rules of the 
London Stock Exchange for companies trading securities 
on the Alternative Investment Market (‘AIM’).

In preparing these financial statements, the Directors are 
required to:
•  select suitable accounting policies and then apply 

them consistently;

•  make judgements and accounting estimates that are 

reasonable and prudent;

•  state whether they have been prepared in accordance 
with IFRSs as adopted by the European Union, subject 
to any material departures disclosed and explained in 
the financial statements; and

•  prepare the financial statements on the going concern 
basis unless it is inappropriate to presume that the 
Company will continue in business.

The Directors are responsible for keeping adequate 
accounting records that are sufficient to show and 
explain the Company’s transactions and disclose with 
reasonable accuracy at any time the financial position 
of the Company and enable them to ensure that the 
financial statements comply with the requirements of 
the Companies Act 2006. They are also responsible for 
safeguarding the assets of the Company and hence for 
taking reasonable steps for the prevention and detection 
of fraud and other irregularities.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018 
29

CORPORATE GOVERNANCE STATEMENT

We note that the AIM rules are due to be updated, which 
is proposed to take effect from 30 June 2018, to require 
a statement as to how we comply with a recognised 
corporate governance code. The Directors intend that 
the Group will comply with the provisions of the Quoted 
Companies Alliance Corporate Governance Code, insofar 
as they are appropriate given its size, nature and stage of 
development. 

PERFORMANCE EVALUATION
The Board has a process for evaluation of its own 
performance which is carried out annually.

BOARD COMMITTEES
As appropriate, the Board has delegated certain 
responsibilities to Board Committees as follows:

BOARD OF DIRECTORS
The Board of Directors (the ‘Board’) consists of a 
Non-Executive Chairman, three Executive Directors 
and three Non-Executive Directors.

The responsibilities of the Non-Executive Chairman 
and the Chief Executive Officer are clearly divided. The 
Chairman is responsible for overseeing the formulation 
of the overall strategy of the Company, the running of the 
Board, ensuring that no individual or group dominates 
the Board’s decision making and ensuring that the 
Non-Executive Directors are properly briefed on matters. 
Prior to each Board meeting, Directors are sent an 
agenda and Board papers for each agenda item to be 
discussed. Additional information is provided when 
requested by the Board or individual Directors.

The Chief Executive Officer has the responsibility for 
implementing the strategy of the Board and managing 
the day to day business activities of the Group through 
his chairmanship of the executive committee.

The Non-Executive Directors bring relevant experience 
from different backgrounds and receive a fixed fee for 
their services and reimbursement of reasonable expenses 
incurred in attending meetings. 

The Board retains full and effective control of the Group. 
This includes responsibility for determining the Group’s 
strategy and for approving budgets and business plans 
to fulfil this strategy. The full Board ordinarily meets 
bi-monthly.

The Company Secretary is responsible to the Board for 
ensuring that Board procedures are followed and that 
the applicable rules and regulations are complied with. 
All Directors have access to the advice and services of 
the Company Secretary, and independent professional 
advice, if required, at the Company’s expense. Removal of 
the Company Secretary would be a matter for the Board. 

I) AUDIT COMMITTEE
The Audit Committee currently comprises 
Clare Spottiswoode CBE (Chairman), Professor 
Sir William Wakeham (Senior Independent Director), 
Professor Keith Jackson and Mike Inglis. 

The Committee monitors the integrity of the Group’s 
financial statements and the effectiveness of the audit 
process. The Committee reviews accounting policies and 
material accounting judgements. The Committee also 
reviews, and reports on, reports from the Group’s 
auditors relating to the Group’s accounting controls. 
It makes recommendations to the Board on the 
appointment of auditors and the audit fee. It has 
unrestricted access to the Group’s auditors. The 
Committee keeps under review the nature and extent 
of non-audit services provided by the external auditors 
in order to ensure that objectivity and independence 
are maintained.

II) REMUNERATION COMMITTEE
The Remuneration Committee comprised Mike Inglis 
(Chairman), Clare Spottiswoode CBE, Professor Keith 
Jackson and Professor Sir William Wakeham 
(Senior Independent Director). 

The Committee is responsible for making 
recommendations to the Board on remuneration 
policy for Executive Directors and the terms of their 
service contracts, with the aim of ensuring that their 
remuneration, including any share options and other 
awards, is based on their own performance and that 
of the Group generally.

III) NOMINATION COMMITTEE
The Nomination Committee comprised Mike Inglis 
(Chairman), Professor Sir William Wakeham (Senior 
Independent Director), Professor Keith Jackson and 
Clare Spottiswoode CBE.

It is responsible for providing a formal, rigorous and 
transparent procedure for the appointment of new 
Directors to the Board and reviewing the performance 
of the Board each year.

WWW.ILIKA.COM
WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT 
 
30

CORPORATE GOVERNANCE STATEMENT

ATTENDANCE AT BOARD MEETINGS AND COMMITTEES
The Directors attended the following Board and committee meetings during the year:

Attendance

Mr. S. Boydell
Prof. B. E. Hayden
Mr. M. Inglis
Mr. G. Purdy
Ms. C. Spottiswoode
Prof. Sir W. Wakeham
Prof. K. Jackson

Board

Audit

Nomination

Remuneration

6/6
6/6
6/6
6/6
5/6
6/6
6/6

–
–
2/2
–
2/2
2/2
2/2

–
–
1/1
–
1/1
1/1
1/1

–
–
2/2
–
2/2
2/2
2/2

RISK MANAGEMENT AND INTERNAL CONTROL
The Board is responsible for the systems of internal control and for reviewing their effectiveness. The internal controls 
are designed to manage rather than eliminate risk and provide reasonable but not absolute assurance against material 
misstatement or loss. The Audit Committee reviews the effectiveness of these systems primarily by discussion with the 
external auditor and by considering the risks potentially affecting the Group.

The Group does not consider it necessary to have an internal audit function due to the small size of the administration 
function. Instead there is a detailed Director review and authorisation of transactions. The annual audit by the Group 
auditor, which tests a sample of transactions, did not highlight any significant system improvements in order to 
reduce risk.

The Group maintains appropriate insurance cover in respect of actions taken against the Executive Directors 
because of their roles, as well as against material loss or claims of the Group. The insured values and type of cover 
are comprehensively reviewed on a periodic basis.

By order of the Board

Mike Inglis 
Chairman 
10 July 2018

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018 
 
 
 
 
 
31

INDEPENDENT AUDITOR’S REPORT
TO THE MEMBERS OF ILIKA PLC

OPINION
We have audited the financial statements of Ilika plc 
(the ‘Parent Company’) and its subsidiaries (the ‘Group’) 
for the year ended 30 April 2018 which comprise the 
Consolidated statement of comprehensive income, the 
Consolidated balance sheet, the Consolidated cash flow 
statement, the Consolidated statement of changes in 
equity, the Company balance sheet, the Company cash 
flow statement, the Company statement of changes in 
equity and notes to the financial statements, including 
a summary of significant accounting policies. 

The financial reporting framework that has been applied 
in the preparation of the financial statements is applicable 
law and International Financial Reporting Standards 
(‘IFRSs’) as adopted by the European Union and, as 
regards the Parent Company financial statements, 
as applied in accordance with the provisions of the 
Companies Act 2006.

In our opinion:
•  the financial statements give a true and fair view of 

the state of the Group’s and of the Parent Company’s 
affairs as at 30 April 2018 and of the Group’s loss for 
the year then ended;

•  the Group financial statements have been properly 
prepared in accordance with IFRSs as adopted by 
the European Union;

•  the Parent Company financial statements have been 

properly prepared in accordance with IFRSs as 
adopted by the European Union and as applied in 
accordance with the provisions of the Companies Act 
2006; and

•  the financial statements have been prepared in 

accordance with the requirements of the Companies 
Act 2006.

BASIS FOR OPINION
We conducted our audit in accordance with International 
Standards on Auditing (UK) (ISAs (UK)) and applicable 
law. Our responsibilities under those standards are further 
described in the Auditor’s responsibilities for the audit of 
the financial statements section of our report. We are 
independent of the Group and the Parent Company in 
accordance with the ethical requirements that are 
relevant to our audit of the financial statements in the 
UK, including the FRC’s Ethical Standard as applied to 
listed entities, and we have fulfilled our other ethical 
responsibilities in accordance with these requirements. 
We believe that the audit evidence we have obtained 
is sufficient and appropriate to provide a basis for 
our opinion.

CONCLUSIONS RELATING TO GOING CONCERN
We have nothing to report in respect of the following 
matters in relation to which the ISAs (UK) require us 
to report to you where:
•  the Directors’ use of the going concern basis of 
accounting in the preparation of the financial 
statements is not appropriate; or

•  the Directors have not disclosed in the financial 

statements any identified material uncertainties that 
may cast significant doubt about the Group’s or the 
Parent Company’s ability to continue to adopt the 
going concern basis of accounting for a period of 
at least 12 months from the date when the financial 
statements are authorised for issue.

KEY AUDIT MATTERS
Key audit matters are those matters that, in our 
professional judgement, were of most significance in our 
audit of the financial statements of the current period 
and include the most significant assessed risks of material 
misstatement (whether or not due to fraud) we identified, 
including those which had the greatest effect on: the 
overall audit strategy, the allocation of resources in the 
audit; and directing the efforts of the engagement team. 
These matters were addressed in the context of our audit 
of the financial statements as a whole, and in forming our 
opinion thereon, and we do not provide a separate 
opinion on these matters.

Key audit matter

How we addressed the matter

Impacting the group financial statements

We have determined that there are no key audit matters to 
communicate in our report that relate to the Group financial 
statements.

Impacting the Parent financial statements only

Investment in subsidiary
As set out in note 21 the  
Company holds an investment 
of £24.2 million in its subsidiary, 
Ilika Technologies Limited. 
At each reporting date, 
management carries out an 
impairment review in accordance 
which includes assessing future 
cash flows and discounting to 
present value and comparing this 
to its carrying amount. The risk 
is in the estimation of future 
cash flows and applying an 
appropriate discount rate to 
arrive at the present value. 

We have tested the integrity 
of the client’s model and 
challenged the impairment 
review through assessing the 
appropriateness of the key 
assumptions such as the 
discount rate, the scale of 
market opportunities and risk 
weighting of estimated future 
cash flows to available market 
information when they are 
fully commercialised. We have 
re-performed the calculation 
of management’s discounted 
cash flow workings.

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT32

INDEPENDENT AUDITOR’S REPORT
TO THE MEMBERS OF ILIKA PLC

OUR APPLICATION OF MATERIALITY
Group materiality: £156,000 (2017: £183,000).

Parent Company materiality: £148,000 (2017: £173,000).

Our Group materiality, for both the current and prior year, 
has been based upon 5 percent of the loss before tax. 
We consider the loss before tax to be one of the principal 
considerations for stakeholders in assessing the 
performance of the Group.

Materiality in respect of the audit of the Parent Company 
has been set using a benchmark of 1 percent of total 
assets for both the current and prior year. We consider 
total assets to be the most appropriate measure for the 
basis of materiality as the Company is a holding company.

We apply the concept of materiality both in planning 
and performing our audit, and in evaluating the effect 
of misstatements. We consider materiality to be the 
magnitude by which misstatements, including omissions, 
could influence the economic decisions of reasonable 
users that are taken on the basis of the financial 
statements. In order to reduce to an appropriately low 
level the probability that any misstatements exceed 
materiality, we use a lower materiality level, performance 
materiality, to determine the extent of testing needed 
Importantly, misstatements below these levels will not 
necessarily be evaluated as immaterial as we also take 
account of the nature of identified misstatements, and 
the particular circumstances of their occurrence, when 
evaluating their effect on the financial statements 
as a whole. 

Performance materiality was set at £117,000. In setting 
the level of performance materiality we considered a 
number of factors including the expected total value 
of known and likely misstatements based on past 
experience and other factors.

Materiality for the trading subsidiary of the Group 
was set at a lower level than that of the Group at 
£148,000 (2016: £173,000).

We agreed with the Audit Committee that we would 
report to the Committee all individual audit differences 
identified during the course of our audit in excess 
of £3,120 (2017: £3,660). We also agreed to report 
differences below these thresholds that, in our view, 
warranted reporting on qualitative grounds.

AN OVERVIEW OF THE SCOPE OF OUR AUDIT
The scope of our Group audit was established by 
obtaining an understanding of the Group, including its 
control environment, and assessing the risks of material 
misstatement.

Both components, Ilika plc and Ilika Technologies Limited, 
are considered significant components and are subject to 
a full-scope audits by BDO LLP.

OTHER INFORMATION
The Directors are responsible for the other information. 
The other information comprises the information included 
in the Annual Report, other than the financial statements 
and our auditor’s report thereon. Our opinion on the 
financial statements does not cover the other information 
and, except to the extent otherwise explicitly stated in 
our report, we do not express any form of assurance 
conclusion thereon.

In connection with our audit of the financial statements, 
our responsibility is to read the other information and, 
in doing so, consider whether the other information is 
materially inconsistent with the financial statements 
or our knowledge obtained in the audit or otherwise 
appears to be materially misstated. If we identify 
such material inconsistencies or apparent material 
misstatements, we are required to determine whether 
there is a material misstatement in the financial 
statements or a material misstatement of the other 
information. If, based on the work we have performed, 
we conclude that there is a material misstatement of 
this other information, we are required to report that fact. 
We have nothing to report in this regard.

OPINIONS ON OTHER MATTERS PRESCRIBED BY 
THE COMPANIES ACT 2006
In our opinion, based on the work undertaken in the 
course of the audit:
•  the information given in the Strategic Report and the 
Directors’ Report for the financial year for which the 
financial statements are prepared is consistent with 
the financial statements; and

•  the Strategic Report and the Directors’ report have 
been prepared in accordance with applicable legal 
requirements.

MATTERS ON WHICH WE ARE REQUIRED TO REPORT 
BY EXCEPTION
In the light of the knowledge and understanding of the 
Group and the Parent Company and its environment 
obtained in the course of the audit, we have not identified 
material misstatements in the Strategic Report or the 
Directors’ Report.

We have nothing to report in respect of the following 
matters in relation to which the Companies Act 2006 
requires us to report to you if, in our opinion:
•  adequate accounting records have not been kept 

by the Parent Company, or returns adequate for our 
audit have not been received from branches not visited 
by us; or

•  the Parent Company financial statements are not in 

agreement with the accounting records and returns; or
•  certain disclosures of Directors’ remuneration specified 

by law are not made; or 

•  we have not received all the information and 

explanations we require for our audit.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018USE OF OUR REPORT
This report is made solely to the Parent Company’s 
members, as a body, in accordance with Chapter 3 
of Part 16 of the Companies Act 2006. Our audit work 
has been undertaken so that we might state to the 
Parent Company’s members those matters we are 
required to state to them in an auditor’s report and 
for no other purpose. To the fullest extent permitted 
by law, we do not accept or assume responsibility to 
anyone other than the Parent Company and the Parent 
Company’s members as a body, for our audit work, 
for this report, or for the opinions we have formed.

Malcolm Thixton (Senior Statutory Auditor)
For and on behalf of BDO LLP, Statutory Auditor
Southampton
United Kingdom

BDO LLP is a limited liability partnership registered in 
England and Wales (with registered number OC305127).

33

RESPONSIBILITIES OF DIRECTORS
As explained more fully in the Directors’ responsibilities 
statement set out on page 28, the Directors are 
responsible for the preparation of the financial 
statements and for being satisfied that they give a 
true and fair view, and for such internal control as 
the Directors determine is necessary to enable the 
preparation of financial statements that are free from 
material misstatement, whether due to fraud or error.

In preparing the financial statements, the Directors 
are responsible for assessing the Group’s and the 
Parent Company’s ability to continue as a going 
concern, disclosing, as applicable, matters related 
to going concern and using the going concern basis 
of accounting unless the Directors either intend to 
liquidate the Group or the Parent Company or to cease 
operations, or have no realistic alternative but to do so.

AUDITOR’S RESPONSIBILITIES FOR THE AUDIT OF 
THE FINANCIAL STATEMENTS
Our objectives are to obtain reasonable assurance about 
whether the financial statements as a whole are free from 
material misstatement, whether due to fraud or error, 
and to issue an auditor’s report that includes our opinion. 
Reasonable assurance is a high level of assurance, but is 
not a guarantee that an audit conducted in accordance 
with ISAs (UK) will always detect a material misstatement 
when it exists.

Misstatements can arise from fraud or error and are 
considered material if, individually or in the aggregate, 
they could reasonably be expected to influence the 
economic decisions of users taken on the basis of 
these financial statements.

A further description of our responsibilities for the 
audit of the financial statements is located on the 
Financial Reporting Council’s website at: www.frc.org.uk/
auditorsresponsibilities. This description forms part of 
our auditor’s report.

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT34

CONSOLIDATED STATEMENT  
OF COMPREHENSIVE INCOME

Turnover

Revenue
UK grants

Cost of sales
Gross profit
Total Administrative expenses

Administrative expenses
Share-based payment charge

Operating loss
Income from short-term deposits

Loss before tax
Taxation
Loss for period/total comprehensive income attributable to owners of parent

Loss per share from continuing operations
Basic
Diluted

Year ended 30 April

Notes

2018
£

2017
£

2

2,051,177 

1,050,667 

798,430 
1,252,747 

(1,090,898)
960,279 

311,946 
738,721 

(574,272)
476,395 

(3,793,686) (3,863,411)
(547,347)

(434,382)

4,410,758 
4,228,068 
(3,267,789) (3,934,363)
23,844 

17,156 

(3,250,633)
353,309 

(3,910,519)
370,274 
(2,897,324) (3,540,245)

(3.67)p
(3.67)p

(4.84)p
(4.84)p

3

5

6

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201835

CONSOLIDATED BALANCE SHEET
COMPANY NUMBER 7187804

Notes

As at 30 April

2018
£

2017
£

ASSETS
Non-current assets
Intangible assets
Property, plant and equipment

Total non-current assets

Current assets
Trade and other receivables
Current tax receivable
Other financial assets – bank deposits
Cash and cash equivalents

Total current assets

Total assets

Issued capital and reserves attributable to owners of parent
Issued share capital
Share premium 
Capital restructuring reserve
Retained earnings

Total equity

LIABILITIES
Current liabilities
Trade and other payables
Provisions
Total liabilities

Total equity and liabilities

7
8

9
5

10

14

11
12

2,453 
578,103 

580,556 

2,581 
451,560 

454,141 

1,024,359 
330,000 
–
2,811,155 

1,116,367 
330,000 
2,900,000 
2,510,884 

4,165,514 

6,857,251 

4,746,070 

7,311,392 

789,911 

789,911 
23,179,756  23,179,756 
6,486,077 
(26,669,347) (24,206,405)

6,486,077 

3,786,397 

6,249,339 

809,673 
150,000 
959,673 

912,053 
150,000 
1,062,053 

4,746,070 

7,311,392 

The notes on pages 38 to 49 form part of these financial statements.

These financial statements were approved and authorised for issue by the Board of Directors on 10 July 2018. 

Mr. M Inglis
Chairman

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT36

CONSOLIDATED CASH FLOW STATEMENT

Cash flows from operating activities
Loss before taxation
Adjustments for:
Amortisation 
Depreciation
Equity settled share-based payments
(Profit)/loss on disposal of plant, property and equipment
Financial income

Year ended 30 April

2018
£

2017
£

(3,250,633)

(3,910,519)

3,282
196,415
434,382
– 
(17,156)

13,014
192,331
547,347
(30,783)
(23,844)

Operating cash flow before changes in working capital, interest and taxes
Decrease/(increase) in trade and other receivables
(Decrease)/increase in trade and other payables

(2,633,710)
92,008 
(102,380)

(3,212,454)
(598,672)
163,925

Cash utilised by operations
Tax received

Net cash flow used in operating activities

Cash flows from investing activities
Interest received
Sale of property, plant and equipment
Purchase of intangible assets
Purchase of property, plant and equipment
(Increase)/decrease in other financial assets

Net cash from/(used in) investing activities

Cash flows from financing activities
Proceeds from issuance of Ordinary Share capital
Cost of share issue

Net cash from financing activities

Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at the start of the period

Cash and cash equivalents at the end of the period

(2,644,082)
353,309 

(3,647,201)
415,274

(2,290,773)

(3,231,927)

17,156 
–
(3,154)
(322,958)
2,900,000 

23,844
40,129

(253,913)
(2,900,000)

2,591,044 

(3,089,940)

– 
– 

– 

6,300,000 
(464,661)

5,835,339 

300,271 
2,510,884 

(486,528) 
2,997,412 

2,811,155 

2,510,884 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201837

CONSOLIDATED STATEMENT OF CHANGES 
IN EQUITY

As at 30 April 2016
Share-based payment
Issue of shares
Cost of share issue
Loss and total comprehensive income

As at 30 April 2017
Share-based payment
Loss and total comprehensive income

As at 30 April 2018

Share 
capital
£

663,911
–
126,000
–
–

Share 
premium 
account
£

Capital 
restructuring 
reserve
£

Total 
attributable to 
equity holders 
of parent
£

Retained 
earnings
£

17,470,417 
–
6,174,000
(464,661)
–

6,486,077  (21,213,507)
547,347 
–
–

3,406,898 
547,347 
6,300,000 
(464,661)
(3,540,245) (3,540,245)

–
–
–
–

789,911 23,179,756
–
–

–
–

6,486,077  (24,206,405)
434,382 
(2,897,324)

–
–

6,249,339
434,382
(2,897,324)

789,911 23,179,756

6,486,077  (26,669,347)

3,786,397 

SHARE CAPITAL
The share capital represents the nominal value of the equity shares in issue.

SHARE PREMIUM ACCOUNT
When shares are issued, any premium paid above the nominal value is credited to the share premium reserve. 

CAPITAL RESTRUCTURING RESERVE
The capital restructuring reserve arises on the accounting for the share for share exchange. It represents the 
difference between the value of the issued equity instruments of Ilika Technologies Limited immediately before 
the share for share exchange and the equity instruments of Ilika plc along with the shares issued to effect the 
share for share exchange. 

RETAINED EARNINGS
The retained earnings reserve records the accumulated profits and losses of the Group since inception of 
the business. 

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT38

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

1  ACCOUNTING POLICIES

BASIS OF PREPARATION
These financial statements have been prepared in accordance with International Financial Reporting Standards 
(‘IFRSs’) adopted by the European Union. The principal accounting policies adopted in the preparation of the 
consolidated financial statements are set out below. The policies have been consistently applied to all of the years 
presented.

The individual financial statements of Ilika plc are shown on page 50 to 54.

BASIS OF CONSOLIDATION
The consolidated financial statements incorporate the financial statements of the Company and entities controlled 
by the Company made up to the reporting date. The Company controls an investee if all three of the following 
elements are present: power over the investee, exposure to variable returns over the investee, and the ability of the 
investee to use its power to affect the variable returns. Control is reassessed whenever facts and circumstances 
indicate that there may be a change in any of these elements of control. All intra-Group transactions, balances, 
income and expenses are eliminated on consolidation.

GOING CONCERN
The financial statements have been prepared on a going concern basis which assumes that the Company will have 
sufficient funds available to enable it to continue to trade for the foreseeable future. In making their assessment that 
this assumption is correct the Directors have undertaken an in-depth review of the business, its current prospects, 
and cash resources as set out below.

The Directors have prepared and reviewed financial forecasts. The Group meets its day to day working capital 
requirements through existing cash resources which, at 30 April 2018, amounted to £2,811,155. After due 
consideration of these forecasts and current cash resources, the Directors consider that the Company and the 
Group have adequate financial resources to continue in operational existence for the foreseeable future (being 
a period of at least 12 months from the date of this report), and for this reason the financial statements have 
been prepared on a going concern basis.

The Directors have also considered the likely sales, contracts and announcements that the Company anticipate 
being able to make over the coming months, the current share price, levels of trading in the Company’s shares 
and past history of raising funds with the Company’s Brokers.

After taking account of all the above factors the Directors believe that as the market becomes more aware of the 
Company’ prospects and the scale of the opportunities that the Company’s technologies create the Company will 
continue to be able to raise any funds required to enable it to continue to trade and grow towards self-sufficiency.

CHANGES IN ACCOUNTING POLICIES

(A) NEW STANDARDS, AMENDMENTS TO STANDARDS OR INTERPRETATIONS ADOPTED EARLY
During the period ended 30 April 2018, there were no new or revised standards, amendments to standards or 
interpretations that have been adopted and affected the amounts reported in the financial statements.

(B) NEW STANDARDS, AMENDMENTS TO STANDARDS OR INTERPRETATIONS NOT YET APPLIED
The following standards, interpretations and amendments, which have not been applied in these financial 
statements and have an effective date commencing after 1 May 2018, will or may have an effect on the Group’s 
future financial statements:

International Accounting 
Standards (IAS/IFRS)

IFRS 15

Revenue from Contracts with Customers

Effective date 
for periods 
commencing

1 January 2018

The Directors will assess the impact of IFRS 15, with particular focus on the recognition of revenue over the life of 
contracts and projects.

No other new standards or amendments are expected to have an effect on the Group.

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018 
 
 
 
39

TURNOVER
Turnover comprises the fair value for the sale of services, net of value added tax and is recognised as follows:

SALES OF SERVICES 
Sales of R&D services are recognised in the accounting period in which the services are rendered, by reference to 
the actual service provided as a proportion of the total services to be provided.

GOVERNMENT GRANTS
Grants that compensate the Group for expenses incurred are recognised in the income statement on a systematic 
basis in the same periods in which the expenses are recognised. 

FINANCIAL INCOME 
Income from short-term deposits is recognised in the income statement as it accrues, using the effective interest 
method.

PENSION AND OTHER POST-RETIREMENT BENEFITS 
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

SHARE-BASED PAYMENT TRANSACTIONS
The Group issues equity-settled share options to all employees. Equity-settled share options are measured at 
fair value at the date of grant. The fair value determined at the grant date of the equity-settled share options is 
expensed on a straight-line basis over the vesting period, based on the Group’s estimate of shares that will 
eventually vest and adjusted for the effect of non-market based vesting conditions. 

The fair value of non-market-based options granted by the Group is measured by use of the Black-Scholes pricing 
model taking into account the following inputs: the exercise price of the option; the life of the option; the market 
price on the date of grant of the option; the expected volatility of the share price; the dividends expected on the 
shares; and the risk free interest rate for the life of the option. The expected life used in the model has been 
adjusted, based on management’s best estimate, for the effects of non-transferability, exercise restrictions, and 
behavioural considerations.

R&D EXPENDITURE
Research expenditure is recognised as an expense when it is incurred.

Its ability to measure reliably the expenditure attributable to the asset under development;

Development expenditure is recognised as an expense except that costs incurred on development projects 
are capitalised as intangible assets to the extent that such expenditure is expected to generate future economic 
benefits. Development expenditure is capitalised if, and only if, an entity within the Group can demonstrate all 
of the following:
i. 
ii.  The product or process is technically and commercially feasible;
iii. 
iv. 
v. 

Its future economic benefits are probable;
Its ability to use or sell the developed asset;
 The availability of adequate technical, financial and other resources to complete the asset under development; 
and

vi.  Its intention is to use or sell the developed asset.

Prior to and during the year ended 30 April 2018, no development expenditure satisfied all of these conditions.

TAXATION
Companies within the Group may be entitled to claim special tax allowances in relation to qualifying R&D 
expenditure (e.g. R&D tax credits). The Group accounts for such allowances as tax credits, which means that they 
are recognised when it is probable that the benefit will flow to the Group and that benefit can be reliably measured. 
R&D tax credits reduce current tax expense and, to the extent the amounts due in respect of them are not settled 
by the balance sheet date, reduce current tax payable. A deferred tax asset is recognised for unclaimed tax credits 
that are carried forward as deferred tax assets. 

Deferred tax is provided on temporary differences between the carrying amounts of assets and liabilities for 
financial reporting purposes and the amounts used for taxation purposes. The amount of deferred tax provided is 
based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax 
rates enacted or substantively enacted at the reporting date.

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT40

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

1  ACCOUNTING POLICIES CONTINUED
A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available 
against which the asset can be utilised.

FOREIGN CURRENCY
Transactions in foreign currencies are translated at the foreign exchange rate ruling at the date of the transaction. 
Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the 
foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are recognised in 
profit or loss. 

PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses.
Where parts of an item of property, plant and equipment have different useful lives, they are accounted for 
as separate items of property, plant and equipment.

Depreciation is charged to the statement of comprehensive income on a straight-line basis over the estimated 
useful lives of each part of an item of property, plant and equipment less their estimated residual value. The 
estimated useful lives are as follows:

Leasehold improvements 
Plant, machinery and equipment 
Fixtures and fittings 

lease term
3–5 years
3–5 years

IMPAIRMENT
The carrying amounts of the Group’s assets are reviewed at each reporting date to determine whether there is any 
indication of impairment. If any such indication exists, the asset’s recoverable amount is estimated at the present 
value of the future expected cash flows associated with the impaired asset.

An impairment loss is recognised whenever the carrying amount of an asset exceeds its recoverable amount. 
Impairment losses are recognised in profit or loss.

INTANGIBLE ASSETS

COMPUTER SOFTWARE
Acquired computer software licences are capitalised on the basis of the costs incurred to acquire and bring to use 
the specific software. These costs are amortised to administrative expenses using the straight-line method over their 
estimated useful lives (1–3 years).

INTELLECTUAL PROPERTY
Acquired intellectual property is included at cost and is amortised to administrative expenses on a straight-line basis 
over its useful economic life of 15 years.

FINANCIAL INSTRUMENTS 
Financial assets and financial liabilities are recognised on the Group’s balance sheet when the Group becomes a 
party to the contractual provisions of the instrument. The Group’s financial assets are all classified as loans and 
receivables and carried at amortised cost. The Group’s financial liabilities are all classified as ‘other’ liabilities which 
are carried at amortised cost. Cash and cash equivalents comprise cash balances and call deposits. Deposits of over 
three months’ maturity, judged at inception, are classified as Other Financial Assets.

KEY SOURCES OF ESTIMATION AND UNCERTAINTY
The preparation of the Group’s financial statements requires management to make estimates and assumptions 
that affect the reported amounts of assets and liabilities, revenues and expenses at the date of the Group’s 
financial statements. The Group’s estimates and judgements are continually evaluated and are based on historical 
experience and other factors, including expectations of future events that are believed to be reasonable under 
the circumstances.

The Directors do not believe there to be any estimates or judgements that have a significant impact on the Group’s 
Financial statements. 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201841

SEGMENT REPORTING

2 
The Group operates in one area of activity, namely the production, design and development of high throughput 
methods of material synthesis, characterisation and screening. The Group has materials development programmes 
addressing a wide range of applications including the solid-state battery, aerospace alloys and electronic materials. 

For management purposes, the Group is analysed by the geographical location of its customer base and business 
development Directors have been appointed to cover the Group’s three territories of focus: Asia, North America 
and Europe. 

Analysis by geographical market:
By destination
 Asia
 Europe
 North America
 UK 

Year ended 30 April

2018
£

2017
£

38,241
134,302
565,887
1,312,747

21,280
–
197,818
831,569

2,051,177

1,050,667

A number of customers individually account for more than 10 percent of the total turnover of the Group. 
The revenues from these companies are indicated below:

UK Grants
Customer 1
Customers less than 10 percent

3  OPERATING LOSS

This is arrived at after charging:

R&D expenditure in the year
Depreciation
Amortisation of intangible assets
Auditor’s remuneration:
 Fees payable to the Group’s auditor for the audit of the Group’s accounts
Fees payable to the Group’s auditor for other services:
 The audit of the Group’s subsidiaries
Operating lease rentals
Share-based payment

Year ended 30 April

2018
£

1,252,747 
565,887 
232,543 

2017
£

738,721
197,819
114,127

2,051,177 

1,050,667

Year ended 30 April

2018
£

2017
£

2,009,023 
196,415 
3,282 

2,110,843
192,331
13,014

22,200

20,700

6,800
207,511
434,382

6,800 
207,511 
547,347

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT42

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

4  EMPLOYEES
The average number of employees during the year, including Executive Directors, was:

Administration
Materials synthesis

Staff costs for all employees, including Executive Directors, consist of:

Wages and salaries
Social security costs
Share-based payment expense
Pension costs

The total remuneration of the Directors of the Group was as follows:

Wages and salaries
Pension costs
Directors’ emoluments
Social security costs
Share-based payment expense

Key management personnel

Year ended 30 April

2018
£

6
34

40

Year ended 30 April

2017
£

6
32

38

2017
£

2018
£

2,055,959
225,480
434,382
150,120

1,954,655
215,648
532,347
139,286

2,865,941 

2,841,936

Year ended 30 April

2018
£

589,607
47,892
637,499
75,072
409,502

2017
£

624,726
47,534
672,260
80,177
428,587

1,122,073

1,181,024

The Directors represent key management personnel and further details are given in the Directors’ Remuneration 
Report on pages 25 to 27.

5 

TAXATION 

(A)  TAX ON LOSS FROM ORDINARY ACTIVITIES
There is no taxation charge due to the losses incurred by the Group during the year. The taxation credit represents 
R&D tax credit claims as follows:

Current tax on loss for the year
Adjustments to prior period

Year ended 30 April

2018
£

330,000
23,309

353,309

2017
£

330,000
40,274

370,274

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201843

(B) FACTORS AFFECTING CURRENT TAX CHARGE
The tax assessed on the loss on ordinary activities for the period is different to the standard rate of corporation tax 
in the UK of 19 percent (2017: 20 percent). The differences are reconciled below:

Loss on ordinary activities before tax

Loss on ordinary activities before tax multiplied by the standard rate of  

corporation tax in the UK of 19 percent (2017: 20 percent)

Effects of:
Expenses not deductible for corporation tax
R&D relief
Origination of unrecognised tax losses
Under provision in previous years

Total tax credit for the year

Year ended 30 April

2018
£

2017
£

(3,120,313)

(3,910,519)

(592,859)

(778,975)

57,772 
(330,000)
535,087 
(23,309)

109,098 
(289,726)
629,603 
(40,274)

(353,309)

(370,274)

UNRECOGNISED DEFERRED TAXATION
There are tax losses available for carry forward against future trading profits of approximately £21,529,000 
(2017: £19,065,000). A deferred tax asset in respect of these losses of approximately £3,660,000 (2017: £3,240,000) 
has not been recognised in the accounts, as the full utilisation of these losses in the foreseeable future is uncertain.

LOSS PER SHARE

6 
Earnings per Ordinary Share have been calculated using the weighted average number of shares in issue during the 
relevant financial periods. The weighted average number of equity shares in issue and the earnings, being loss after 
tax, are as follows:

Weighted average number of equity shares

Earnings, being loss after tax

Loss per share

Year ended 30 April

2018
Number

2017
Number

78,991,110   73,122,617

2018
£

2017
£

(2,897,324) (3,540,245)

2018
Pence

(3.67)

2017
Pence

(4.84)

The loss attributable to Ordinary Shareholders and weighted average number of Ordinary Shares for the purpose 
of calculating the diluted earnings per Ordinary Share are identical to those used for basic earnings per share. 
This is because the exercise of share options would have the effect of reducing the loss per Ordinary Share and is 
therefore not dilutive. At 30 April 2018, there were 6,727,499 options outstanding (2017: 7,741,892) as detailed in 
notes 14 and 18.

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT44

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

7 

INTANGIBLE ASSETS

Cost
As at 30 April 2016
Disposals

As at 30 April 2017
Additions

As at 30 April 2018

Amortisation
As at 30 April 2016
Provided for the year
Disposals

As at 30 April 2017
Provided for the year

As at 30 April 2018

Net book value
As at 30 April 2016

As at 30 April 2017

As at 30 April 2018

Software 
licences
£

Intellectual 
property
£

Total
£

46,293
(7,250)

39,043 
3,154 

42,197 

30,698 
13,014 
(7,250)

36,462 
3,282 

39,744

15,595 

2,581 

2,453 

75,000

75,000 
– 

75,000 

75,000
–
–

75,000
–

121,293 
(7,250)

114,043 
3,154 

117,197 

105,698 
13,014 
(7,250)

111,462 
3,282 

75,000 

114,744 

–

–

–

15,595 

2,581 

2,453 

The amortisation charge of £3,282 (2017: £13,014) is included within administrative expenses.

8 

PROPERTY, PLANT AND EQUIPMENT

Cost
As at 30 April 2016
Additions
Disposals

As at 30 April 2017
Additions
Disposals

As at 30 April 2018

Depreciation
As at 30 April 2016
Provided for the year
Disposals

As at 30 April 2017
Provided for the year
Disposals

As at 30 April 2018

Net book value
As at 30 April 2016

As at 30 April 2017

As at 30 April 2018

Leasehold 
improvements
£ 

Plant, 
machinery and 
equipment
£

Fixtures and 
fittings
£ 

Total
£

567,500 
– 
– 

567,500 
33,974 
– 

4,523,026 
253,172 
(234,408)

4,541,790 
287,969 
(11,939)

167,525
741
(546)

167,720
1,015
–

5,258,051
253,913 
(234,954)

5,277,010 
322,958 
(11,939)

601,474 

4,817,820 

168,735

5,588,029 

567,500 
– 
– 

567,500 
8,144 
– 

4,131,647 
187,591 
(225,062)

4,094,176 
185,482 
(11,939)

159,580
4,740
(546)

163,774
2,789
–

4,858,727 
192,331 
(225,608)

4,825,450 
196,415 
(11,939)

575,644 

4,267,719 

166,563

5,009,926 

– 

– 

391,379 

447,614 

25,830 

550,101 

7,945

3,946

2,172

399,324 

451,560 

578,103 

There are no commitments for capital expenditure contracted but not provided for (2017: £nil).

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201845

9 

TRADE AND OTHER RECEIVABLES

Trade receivables
Prepayments 
Other receivables
Accrued income

The ageing of trade receivables is as follows:

0–29 days
30–59 days

As at 30 April

2018
£

5,163 
337,887 
242,097 
439,212 

2017
£

133,655
299,032
312,769
370,911

1,024,359 

1,116,367

As at 30 April

2018
£

5,163 
– 

5,163 

2017
£

67,181 
66,474 

133,655 

Included in other receivables is an amount of £150,000 (2017: £150,000) which represents cash held in a separate 
bank account used as security against a bond provided by the Company’s bankers (refer to note 12). The bond 
relates to the potential dilapidations costs due at the end of the Company’s property lease. 

10  CASH AND CASH EQUIVALENTS

Current bank accounts
Short-term deposits with less than three months’ maturity

11  TRADE AND OTHER PAYABLES

Trade payables
Other payables
Other taxes and social security costs
Accruals

The ageing of financial liabilities is as follows:

0–29 days
30–59 days
60–89 days
90+ days

As at 30 April

2018
£

2017
£

435,108 
2,376,047 

238,371 
2,272,513 

2,811,155 

2,510,884 

As at 30 April

2018
£

269,191 
24,927 
51,372 
464,183 

2017
£

308,635
28,454
57,768
517,196

809,673 

912,053 

As at 30 April

2018
£

482,162 
133,788 
17,404 
124,947 

2017
£

562,725
163,854
3,010
124,696

758,301 

854,285

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT46

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

12  PROVISIONS

As at 1 May 2017 and at 30 April 2018

All provisions are due within one year.

Leasehold
 dilapidations
£

150,000

Leasehold dilapidations relate to the estimated cost of returning a leasehold property to its original state at the end 
of the lease in accordance with the lease terms.

13  FINANCIAL INSTRUMENTS 
The risks associated with financial instruments are set out below.

FOREIGN CURRENCY RISK 
The Group buys goods and services in currencies other than Sterling. The Group’s non-Sterling liabilities and cash 
flows can be affected by movements in exchange rates. The Group has denominated some of it sales transactions 
in non-Sterling currencies and has entered into a forward exchange contract to mitigate this risk. 

CREDIT RISK 
The Group’s credit risk is attributable to its trade receivables and banking deposits. The Group places its deposits 
with reputable financial institutions to minimise credit risk. The maximum exposure to credit risk for each period is 
the amount disclosed above as total loans and receivables. For the periods above there were no trade receivables 
which were past due or impaired. Risk is further mitigated through the use of credit limits, but also through the 
nature of the customers, who, for the most part, are large multinationals.

LIQUIDITY RISK 
The Group’s policy is to maintain adequate cash resources to meet liabilities as they fall due. All Group payable 
balances fall due for payment within one year. Cash balances are placed on deposit for varying periods with 
reputable banking institutions to ensure there is limited risk of capital loss. The Group does not maintain an 
overdraft facility. 

INTEREST RATE RISK 
The main risk arising from the Group’s financial instruments is interest rate risk. The Group placed deposits surplus 
to short-term working capital requirements with a variety of reputable UK-based banks. These balances are placed 
at floating rates of interest and deposits have maturities of one to 12 months. The Group’s cash and short-term 
deposits are set out in note 11. Floating-rate financial assets comprise cash on deposit and cash at bank. Short-term 
deposits are placed with banks for periods of up to 12 months and are categorised as floating-rate financial assets. 
Contracts in place at 30 April 2018 had a weighted average period to maturity of 28 days (2017: 26 days) and a 
weighted average annualised rate of interest of 0.6 percent (2017: 0.6 percent).

INTEREST RATE RISK SENSITIVITY ANALYSIS 
It is estimated that a change in base rate to zero would have increased the Group’s loss before taxation for the year 
to 30 April 2018 by approximately £17,000 (2017: £24,000).

It is estimated that an increase in base rate by 1 percent would decrease the Group’s loss before taxation for the year 
to 30 April 2018 by approximately £30,000 (2017: £45,000)

There is no difference between the book and fair value of financial assets and liabilities.

CAPITAL MANAGEMENT
The primary aim of the Group’s capital management is to safeguard the Group’s ability to continue as a going 
concern, to support its businesses and maximise shareholder value. The Group monitors its capital structure and 
makes adjustments as and when it is deemed necessary and appropriate to do so using such methods as the issuing 
of new shares. At present all funding is raised by equity. 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201847

14  SHARE CAPITAL

Authorised
78,402,710 Ordinary Shares of £0.01 each 
1,781,400 Convertible Preference Shares of £0.01 each 

Allotted, called up and fully paid
78,402,710 Ordinary Shares of £0.01 each 
588,400 Convertible Preference Shares of £0.01 each 

As at 30 April

2018
£

2017
£

784,027
17,814

784,027
17,814

784,027
5,884

789,911

784,027
5,884

789,911

SHARE RIGHTS
The Ordinary Share and preference shares rank pari passu in all respects other than:
•  The profits which the Group may determine to distribute in respect of any financial period shall be distributed 
only among the holders of the Ordinary Shares. The Preference Shares shall not entitle the holders of them to 
any share in such distributions

•  On a return of capital or assets on a liquidation, reduction of capital or otherwise the surplus assets of the Group 

remaining after payment of its obligations shall be applied:
–  First, in paying to the holders of the Preference Shares the amount paid thereon, being the amount equal to 

the par value of the preference shares excluding any premium; and

–  Secondly, the balance of such surplus assets shall belong to and be distributed amongst the holders of the 

Ordinary Shares.

The Preference Shareholders have the right, at any time, to convert the preference shares held to the same number 
of Ordinary Shares. There are no further redemption rights.

SHARE OPTIONS AND WARRANTS
Employee related share options are disclosed in note 18. 

15  OPERATING LEASES
The total future minimum rent payable under non-cancellable operating leases is as follows:

Property leases which expire:
Within one year

2018
£

2017
£

97,143

97,143

16  PENSIONS
The Group operates a defined contribution Group personal pension scheme. The pension cost charge for the period 
represents contributions payable by the Group to the scheme and amounted to £150,120 (2017: £139,286). 

17  RELATED PARTY TRANSACTIONS
The Directors consider that no one party controls the Group.

Details of key management personnel and their compensation are given in note 4 and in the Directors’ 
Remuneration Report on pages 25 to 27.

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT48

NOTES TO THE CONSOLIDATED FINANCIAL 
STATEMENTS

18  SHARE-BASED PAYMENTS EXPENSE AND SHARE OPTIONS

SHARE-BASED PAYMENT EXPENSE
The Group has incentivised and motivated staff through the grant of share options under the Enterprise 
Management Incentive (‘EMI’) scheme and through unapproved share options.

At 30 April 2018, the following options, whose fair values have been fully charged to the consolidated statement of 
total comprehensive income, were outstanding:

Approved share options:

Date of grant

02/02/09
01/12/09
14/05/10
01/02/12

Unapproved share options:

Date of grant

11/11/08
14/05/10

BLACK-SCHOLES VALUATION

Outstanding:
At start of the period
Granted in the period
Lapsed in the period

At the end of the period

Number of 
shares

Period of
 option

Exercise
price per share

53,000
90,000
23,200
39,634

10 years
10 years
10 years
10 years

£0.80
£0.80
£0.51
£0.53

Number of 
shares

Period of
 option

Exercise
price per share

40,000
1,897,800

10 years
10 years

£2.4283
£0.51

Weighted average exercise price

Number

2018
£

2017
£

2018

2017

0.4930
0.1721
0.7652

0.2856

0.5021
0.4850
0.7384

5,710,692 
1,266,117 
(2,170,310)

4,956,912 
906,500 
(152,720)

0.4930

4,806,499 

5,710,692 

The exercise price of options outstanding at the end of the period ranged between £0.01 and £2.4283 and their 
weighted average contractual life was 8.0 years (2017: 8.1 years). These share options are exercisable and must be 
exercised within 10 years from the date of grant. 

STOCHASTIC VALUATION

Outstanding:
At start of the period
Lapsed during the period

At the end of the period

Weighted average exercise price

Number

2018
£

0.51
0.51

0.51

2017
£

0.51
–

0.51

2018

2017

1,923,900
(2,900)

1,923,900
–

1,921,000

1,923,900

The exercise price of options outstanding at the end of the period was £0.51 (2017: £0.51) and their weighted 
average contractual life was three years (2017: four years).

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201849

ILIKA PLC EXECUTIVE SHARE OPTION SCHEME 2010
At 30 April 2018 the following share options were outstanding in respect of the Ilika plc Executive Share Option 
Scheme 2010:

Date of grant

14/05/10
01/02/12
22/03/16
16/03/17
08/02/18

Number of 
shares

Period of
 option

Exercise
price per share

23,200
35,884
729,090
757,500
1,026,250

10 years
10 years
10 years
10 years
10 years

£0.51
£0.53
£0.59
£0.485
£0.21

Members of staff in the Group have options in respect of Ordinary Shares in Ilika plc, which are conditional upon the 
achievement of a series of financial and commercial milestones.

1,676,610 options lapsed in the year.

ILIKA PLC UNAPPROVED SHARE OPTIONS
At 30 April 2018 the following share options were outstanding in respect of Ilika plc unapproved share options:

Date of grant

11/11/08
14/05/10
26/02/15
30/09/15
30/09/15

Number of 
shares

Period of
 option

Exercise
price per share

40,000
1,897,800
177,900
160,000
1,674,908

10 years
10 years
10 years
10 years
10 years

£2.4283
£0.51
£0.815
£0.688
£0.01

496,600 options lapsed in the year and no options were exercised.

There are 2,139,884 options which were capable of being exercised as at 30 April 2018.

Share-based payment expense
 Black-Scholes calculation

2018
£

2017
£

434,382

547,347

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT50

COMPANY BALANCE SHEET OF ILIKA PLC 
COMPANY NUMBER 7187804

ASSETS
Non-current assets
 Investments in subsidiary undertaking
 Amount due from subsidiary undertaking

Current assets
Trade and other receivables

Total assets

Equity
 Issued share capital
 Share premium 
 Retained earnings

LIABILITIES
Current liabilities
 Trade and other payables

Total liabilities

Total equity and liabilities

Notes

As at 30 April

2018
£

2017
£

21 24,229,684
23

121,339
33,834 24,108,345

24,263,518 24,229,684

22

10,119

13,646

24,273,637 24,243,330

789,911

789,911
23,158,967 23,158,967
146,304 

181,889

24,130,767 24,095,182

24

142,870

142,870

148,148

148,148

24,273,637 24,243,330

No profit and loss account is presented for the Company as permitted by Section 408 of the Companies Act 2006. 
The Company’s loss for the year was £398,797 (2017: loss of £509,726).

The notes on pages 53 to 54 form part of these financial statements.

These financial statements were approved and authorised for issue by the Board of Directors on 10 July 2018. 

Mr. M Inglis
Chairman

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201851

COMPANY CASH FLOW STATEMENT

Cash flows from operating activities
Loss before tax
Adjustments for:
Equity settled share-based payments

Operating cash flow before changes in working capital, interest and taxes
Decrease/(increase) in trade and other receivables
(Decrease)/increase in trade and other payables
Increase in amounts due from subsidiary undertaking

Cash utilised by operations

Cash flows from financing activities
Proceeds from issuance of Ordinary Share capital
Costs of share issue

Net cash from financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents at the start of the period

Cash and cash equivalents at the end of the period

Year end 30 April

2018
£

2017
£

(398,797)

(509,726)

434,382

547,347 

35,585
3,527
(5,278)

37,621 
(11,127)
11,842 
(33,834) (5,873,675)

– 

(5,835,339)

– 
– 

–

–
–

–

6,300,000 
(464,661)

5,835,339 

–
–

–

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT52

COMPANY STATEMENT OF CHANGES IN EQUITY

As at 30 April 2016
Issue of shares
Costs of issue
Share-based payment
Profit and total comprehensive income

As at 30 April 2017
Share-based payment
Profit and total comprehensive income

As at 30 April 2018

Share 
capital
£

Share 
premium 
account
£

663,911
126,000
–
–
–

17,449,628
6,174,000
(464,661)
–
–

789,911 23,158,967
–
–

–
–

Total 
attributable to 
equity holders 
of parent
£

Retained 
earnings
£

108,683  18,222,222 
6,300,000 
(464,661)
547,347 
(509,726)

– 
– 
547,347 
(509,726)

146,304  24,095,182 
434,382 
434,382 
(398,477)
(398,797)

789,911 23,158,967

181,889  24,130,767 

SHARE CAPITAL
The share capital represents the nominal value of the equity shares in issue.

SHARE PREMIUM ACCOUNT
When shares are issued, any premium paid above the nominal value is credited to the share premium reserve. 

RETAINED EARNINGS
The retained earnings reserve records the accumulated profits and losses of the Company since inception of 
the business. 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201853

NOTES TO THE COMPANY FINANCIAL STATEMENTS

19  ACCOUNTING POLICIES

BASIS OF PREPARATION
These financial statements have been prepared in accordance with International Financial Reporting Standards 
(‘IFRSs’) adopted by the European Union.

TAXATION, SHARE-BASED PAYMENTS AND FINANCIAL INSTRUMENTS
For the relevant accounting policies please see note 1.

INVESTMENTS IN SUBSIDIARY UNDERTAKINGS
Investments in subsidiary undertakings where the Company has control are stated at cost less any provision 
for impairment.

KEY SOURCES OF ESTIMATION AND UNCERTAINTY
The Company holds a significant investment in its subsidiary, Ilika Technologies Limited, of £24.3 million 
(2017:£0.1 million). In assessing the carrying value of this asset for impairment, the Directors have exercised 
judgement in estimating its recoverable amount. The determination of the valuation for this asset is based on the 
discounted estimated future cash flows generated from out-licensing transactions. The valuation is derived from a 
financial model that evaluates a range of potential outcomes from what are considered the key variables, including 
the probability of licensing agreements being signed, the expected licensing terms that will be negotiated and 
the anticipated revenues generated as a result. Given the level of headroom indicated by the impairment review, 
the discount rate assumption is not considered to be sufficiently sensitive to change to impact the conclusion of 
the review.

20  DIRECTORS’ REMUNERATION
The only employees of the Company are the Directors. In respect of Directors’ remuneration, the disclosures 
required by Schedule 5 to the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 
2008 are included in the detailed disclosures in the audited section of the Directors’ Remuneration Report on pages 
25 to 27, which are ascribed as forming part of these financial statements.

INVESTMENT IN SUBSIDIARY UNDERTAKING

21 
Investments in Group undertakings are stated at cost. 

Ilika plc has a wholly-owned subsidiary, Ilika Technologies Limited. Ilika Technologies Limited (Incorporated in the 
UK) made a loss for the year of £2,498,527 (2017: £3,030,519) and had net assets as at 30 April 2018 of £3,885,314 
(2017: net liabilities of £17,724,504).

At 1 May 
Additions

At 30 April

2018
£

121,339
24,108,345

24,229,684

2017
£

121,339
– 

121,339

The registered address of Ilika Technologies Limited is Kenneth Dibben House, Enterprise Road, University of 
Southampton Science Park, Chilworth, Southampton, SO16 7NS.

During the year, the Company converted intercompany debtors of £24,108,345 into Ordinary Shares in its 
subsidiary, Ilika Technologies Limited.

22  TRADE AND OTHER RECEIVABLES

Prepayments

23  AMOUNT DUE FROM SUBSIDIARY UNDERTAKING

Ilika Technologies Limited

2018
£

2017
£

10,119

13,646 

2018
£

2017
£

33,834 24,108,345

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT 
54

NOTES TO THE COMPANY FINANCIAL STATEMENTS

24  TRADE AND OTHER PAYABLES

Trade payables
Accruals

2018
£

26,170
116,700

142,870

2017
£

32,903
115,245

148,148

25  RELATED PARTY TRANSACTIONS
During the year the Company recharged costs totalling £211,618 (2017: £163,744) to its subsidiary, Ilika Technologies 
Limited. Amounts owed to Ilika Technologies Limited are disclosed in note 23.

Details of key management personnel and their compensation are given in note 4 and in the Directors’ 
Remuneration Report on pages 25 to 27.

The Directors consider that no one party controls the Company.

26  FINANCIAL INSTRUMENTS

CREDIT RISK 
The Company’s credit risk is attributable to its receivables of £33,834 from its subsidiary undertaking, Ilika 
Technologies Limited. As at 30 April 2018, Ilika Technologies Limited had net assets of £3,885,314. The Company 
makes no allowance for impairment of this balance. Impairment is considered by management based on prior 
experience, current market and third party intelligence while considering the current economic environment. 

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 201855

CORPORATE DIRECTORY

COMPANY NUMBER 

7187804

DIRECTORS
EXECUTIVE 

NON-EXECUTIVE 

Graeme Purdy
Prof. Brian Hayden
Steve Boydell

Mike Inglis (Chairman)
Clare Spottiswoode CBE
Prof. Sir William Wakeham
Prof. Keith Jackson

SECRETARY 

Steve Boydell

REGISTERED OFFICE 

Kenneth Dibben House
Enterprise Road
University of Southampton Science Park
Chilworth
Southampton
SO16 7NS

WEBSITE 

www.ilika.com

ADVISERS
INDEPENDENT AUDITORS 

NOMINATED ADVISER AND BROKER 

REGISTRARS 

PUBLIC RELATIONS 

REMUNERATION CONSULTANTS

BDO LLP
Arcadia House
Maritime Walk
Ocean Village
Southampton
SO14 3TL

Liberum Capital Limited
Ropemaker Place
25 Ropemaker Street
London
EC2Y 9LY

Computershare Investor Services PLC
The Pavilions
Bridgwater Road
Bristol
BS13 8AE

Walbrook PR Limited
4 Lombard Street
London
EC3V 9HD

FIT Remuneration Consultants LLP
5 Fitzhardinge Street
London
W1H 6ED

WWW.ILIKA.COM

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018FINANCIAL STATEMENTSCORPORATE GOVERNANCESTRATEGIC REPORT56

NOTES

ILIKA PLC ANNUAL REPORT AND ACCOUNTS 2018WWW.ILIKA.COM

Ilika plc
Kenneth Dibben House
Enterprise Road
University of Southampton Science Park
Chilworth
Southampton
SO16 7NS
United Kingdom

E  info@ilika.com
T  +44 (0)23 8011 1400

www.ilika.com

I

l

i

k

a

p

l

c

A

n

n

u

a

l

R

e

p

o

r

t

a

n

d

A

c

c

o

u

n

t

s

2

0

1

8